EurekaMag Full Text Articles Chapter 11,586

Moore, A.B.; He, H.; Yoshida, A.; Rico, P.J.; Haseman, J.K.; Dixon, D. 2000: Transforming growth factor-alpha, epidermal growth factor receptor, and PCNA immunoexpression in uterine leiomyosarcomas and leiomyomas in B6C3F1 mice. Experimental and Toxicologic Pathology: Official Journal of the Gesellschaft für Toxikologische Pathologie 52(3): 195-200

Daudet, N.; Ripoll, C.; Lenoir, M. 2002: Transforming growth factor-alpha-induced cellular changes in organotypic cultures of juvenile, amikacin-treated rat organ of corti. Journal of Comparative Neurology 442(1): 6-22

Watson, S.A.; Robinson, K.E.; McWilliams, D.; Michaeli, D.; Smith, A.M.; Robinson, G. 2000: Transforming growth factor-alpha-mediated growth pathways in human gastro-intestinal cell lines in relation to the gastrin autocrine pathway. International Journal of Cancer 87(1): 20-28

Hansson, T.; Ulfgren, A-K.; Lindroos, E.; DannAEus, A.; Dahlbom, I.; Klareskog, L. 2002: Transforming growth factor-beta (TGF-beta) and tissue transglutaminase expression in the small intestine in children with coeliac disease. Scandinavian Journal of Immunology 56(5): 530-537

Topper, J.N. 2001: Transforming growth factor-beta (TGF-beta) and vascular disease: CARP as a putative TGF-beta target gene in the vessel wall. Circulation Research 88(1): 5-6

De Crescenzo, G.; Pham, P.L.; Durocher, Y.; O'Connor-McCourt, M.D. 2003: Transforming growth factor-beta (TGF-beta) binding to the extracellular domain of the type II TGF-beta receptor: receptor capture on a biosensor surface using a new coiled-coil capture system demonstrates that avidity contributes significantly to high affinity binding. Journal of Molecular Biology 328(5): 1173-1183

Zhao, Y. 1999: Transforming growth factor-beta (TGF-beta) type I and type II receptors are both required for TGF-beta-mediated extracellular matrix production in lung fibroblasts. Molecular and Cellular Endocrinology 150(1-2): 91-97

El-Gamel, A.; Awad, M.R.; Hasleton, P.S.; Yonan, N.A.; Hutchinson, J.A.; Campbell, C.S.; Rahman, A.H.; Deiraniya, A.K.; Sinnott, P.J.; Hutchinson, I.V. 1999: Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 18(6): 517-523

Han, S.H.; Yea, S.S.; Jeon, Y.J.; Yang, K.H.; Kaminski, N.E. 1998: Transforming growth factor-beta 1 (TGF-beta1) promotes IL-2 mRNA expression through the up-regulation of NF-kappaB, AP-1 and NF-AT in EL4 cells. Journal of Pharmacology and Experimental Therapeutics 287(3): 1105-1112

Walboomers, X.F.; Dalton, B.A.; Evans, M.D.; Steele, J.G.; Jansen, J.A. 2002: Transforming growth factor-beta 1, 2, and 3 can inhibit epithelial tissue outgrowth on smooth and microgrooved substrates. Journal of Biomedical Materials Research 60(3): 445-451

Yuen, M.F.; Norris, S.; Evans, L.W.; Langley, P.G.; Hughes, R.D. 2002: Transforming growth factor-beta 1, activin and follistatin in patients with hepatocellular carcinoma and patients with alcoholic cirrhosis. Scandinavian Journal of Gastroenterology 37(2): 233-238

Jiang, Y.; Mclennan, I.S.; Koishi, K.; Hendry, I.A. 2000: Transforming growth factor-beta 2 is anterogradely and retrogradely transported in motoneurons and up-regulated after nerve injury. Neuroscience 97(4): 735-742

Inoue, K.; Yamazaki, H.; Manabe, Y.; Fukuda, C.; Hanai, K.; Fushiki, T. 1999: Transforming growth factor-beta activated during exercise in brain depresses spontaneous motor activity of animals. Relevance to central fatigue. Brain Research 846(2): 145-153

Goodman, G.R.; Dissanayake, I.R.; Bowman, A.R.; Pun, S.; Ma, Y.; Jee, W.S.; Bryer, H.P.; Epstein, S. 2001: Transforming growth factor-beta administration modifies cyclosporine A-induced bone loss. Bone 28(6): 583-588

Gobbi, H.; Dupont, W.D.; Simpson, J.F.; Plummer, W.D.; Schuyler, P.A.; Olson, S.J.; Arteaga, C.L.; Page, D.L. 1999: Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia. Journal of the National Cancer Institute 91(24): 2096-2101

Pitts, R.L.; Wang, S.; Jones, E.A.; Symes, A.J. 2001: Transforming growth factor-beta and ciliary neurotrophic factor synergistically induce vasoactive intestinal peptide gene expression through the cooperation of Smad, STAT, and AP-1 sites. Journal of Biological Chemistry 276(23): 19966-19973

Grände, M.; Franzen, A.; Karlsson, J-Olof.; Ericson, L.E.; Heldin, N-Erik.; Nilsson, M. 2002: Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. Journal of Cell Science 115(Pt 22): 4227-4236

Bickerstaff, A.A.; VanBuskirk, A.M.; Wakely, E.; Orosz, C.G. 2000: Transforming growth factor-beta and interleukin-10 subvert alloreactive delayed type hypersensitivity in cardiac allograft acceptor mice. Transplantation 69(7): 1517-1520

Kabayama, S. 1999: Transforming growth factor-beta and its receptors are highly expressed in epiphyseal growth plate. Medical Journal of Kagoshima University 50(4): 117-122

Duvernelle, C.; Freund, Véronique.; Frossard, N. 2003: Transforming growth factor-beta and its role in asthma. Pulmonary Pharmacology and Therapeutics 16(4): 181-196

Friedenberg, W.R.; Salzman, S.A.; Phan, S.M.; Burmester, J.K. 1999: Transforming growth factor-beta and multidrug resistance in chronic lymphocytic leukemia. Medical Oncology 16(2): 110-118

Ständer, M.; Naumann, U.; Wick, W.; Weller, M. 1999: Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell and Tissue Research 296(2): 221-227

Breier, G.; Blum, S.; Peli, J.; Groot, M.; Wild, C.; Risau, W.; Reichmann, E. 2002: Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis. International Journal of Cancer 97(2): 142-148

Liu, P.; Menon, K.; Alvarez, E.; Lu, K.; Teicher, B.A. 2000: Transforming growth factor-beta and response to anticancer therapies in human liver and gastric tumors in vitro and in vivo. International Journal of Oncology 16(3): 599-610

Schuster, N.; Bender, H.; Rössler, O.G.; Philippi, A.; Dünker, N.; Thiel, G.; Krieglstein, K. 2003: Transforming growth factor-beta and tumor necrosis factor-alpha cooperate to induce apoptosis in the oligodendroglial cell line OLI-neu. Journal of Neuroscience Research 73(3): 324-333

Lúdvíksson, B.R.; Gunnlaugsdóttir, B. 2003: Transforming growth factor-beta as a regulator of site-specific T-cell inflammatory response. Scandinavian Journal of Immunology 58(2): 129-138

Hurteau, J.A.; Allison, B.; Sutton, G.P.; Moore, D.H.; Look, K.Y.; Hurd, W.; Bigsby, R.M. 1999: Transforming growth factor-beta differentially inhibits epithelial ovarian carcinoma cells from primary and metastatic isolates without up-regulation of p21WAF1. Cancer 85(8): 1810-1815

Dickson, C.; Webster, D.R.; Johnson, H.; Cecilia Millena, A.; Khan, S.A. 2002: Transforming growth factor-beta effects on morphology of immature rat Leydig cells. Molecular and Cellular Endocrinology 195(1-2): 65-77

Moriuchi, M.; Moriuchi, H. 2002: Transforming growth factor-beta enhances human T-cell leukemia virus type I infection. Journal of Medical Virology 67(3): 427-430

Lyall, F.; Simpson, H.; Bulmer, J.N.; Barber, A.; Robson, S.C. 2001: Transforming growth factor-beta expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction. American Journal of Pathology 159(5): 1827-1838

Nagineni, C.N.; Detrick, B.; Hooks, J.J. 2002: Transforming growth factor-beta expression in human retinal pigment epithelial cells is enhanced by Toxoplasma gondii: a possible role in the immunopathogenesis of retinochoroiditis. Clinical and Experimental Immunology 128(2): 372-378

Cardillo, M.R.; Petrangeli, E.; Ravenna, L.; Salvatori, L.; Di Silverio, F. 1998: Transforming growth factor-beta expression in human testicular neoplasms. Analytical and Quantitative Cytology and Histology 20(6): 461-469

Cardillo, M.R.; Petrangeli, E.; Perracchio, L.; Salvatori, L.; Ravenna, L.; Di Silverio, F. 2000: Transforming growth factor-beta expression in prostate neoplasia. Analytical and Quantitative Cytology and Histology 22(1): 1-10

Billia, F.; Carter, K.; Rao, V.; Gorczynski, R.; Feindel, C.; Ross, H.J. 2002: Transforming growth factor-beta expression is significantly lower in hearts preserved with blood/insulin versus crystalloid cardioplegia. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 21(8): 918-922

Kuwahara, F.; Kai, H.; Tokuda, K.; Kai, M.; Takeshita, A.; Egashira, K.; Imaizumi, T. 2002: Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 106(1): 130-135

Fondal, W.; Sampson, C.; Sharp, G.C.; Braley-Mullen, H. 2001: Transforming growth factor-beta has contrasting effects in the presence or absence of exogenous interleukin-12 on the in vitro activation of cells that transfer experimental autoimmune thyroiditis. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 21(11): 971-980

Nishimura, T.; Yamamoto, H.; deSerres, S.; Meyer, A.A. 1999: Transforming growth factor-beta impairs postburn immunoglobulin production by limiting B-cell proliferation, but not cellular synthesis. Journal of Trauma 46(5): 881-885

Lee, C.; Sintich, S.M.; Mathews, E.P.; Shah, A.H.; Kundu, S.D.; Perry, K.T.; Cho, J.S.; Ilio, K.Y.; Cronauer, M.V.; Janulis, L.; Sensibar, J.A. 1999: Transforming growth factor-beta in benign and malignant prostate. Prostate 39(4): 285-290

Kalliomäki, M.; Ouwehand, A.; Arvilommi, H.; Kero, P.; Isolauri, E. 1999: Transforming growth factor-beta in breast milk: a potential regulator of atopic disease at an early age. Journal of Allergy and Clinical Immunology 104(6): 1251-1257

Mierisch, C.M.; Cohen, S.B.; Jordan, L.C.; Robertson, P.G.; Balian, G.; Diduch, D.R.; Robertson, P.G. 2002: Transforming growth factor-beta in calcium alginate beads for the treatment of articular cartilage defects in the rabbit. Arthroscopy: the Journal of Arthroscopic and Related Surgery: Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association 18(8): 892-900

Zhang, W.Guang.; Khan, A.Naveed.; Kim, K.Jun.; Stins, M.; Kim, K.Sik. 2002: Transforming growth factor-beta increases Escherichia coli K1 adherence, invasion, and transcytosis in human brain microvascular endothelial cells. Cell and Tissue Research 309(2): 281-286

Franchimont, N.; Rydziel, S.; Canalis, E. 2000: Transforming growth factor-beta increases interleukin-6 transcripts in osteoblasts. Bone 26(3): 249-253

Schuster, N.; Dünker, N.; Krieglstein, K. 2002: Transforming growth factor-beta induced cell death in the developing chick retina is mediated via activation of c-jun N-terminal kinase and downregulation of the anti-apoptotic protein Bcl-X(L). Neuroscience Letters 330(3): 239-242

Tardif, G.; Reboul, P.; Dupuis, M.; Geng, C.; Duval, N.; Pelletier, J.P.; Martel-Pelletier, J. 2001: Transforming growth factor-beta induced collagenase-3 production in human osteoarthritic chondrocytes is triggered by Smad proteins: cooperation between activator protein-1 and PEA-3 binding sites. Journal of Rheumatology 28(7): 1631-1639

Chung, E.J.; Choi, S.H.; Shim, Y.H.; Bang, Y.J.; Hur, K.C.; Kim, C.W. 2000: Transforming growth factor-beta induces apoptosis in activated murine T cells through the activation of caspase 1-like protease. Cellular Immunology 204(1): 46-54

Chang, C.-J.; Liao, C.-H.; Wang, F.-H.; Lin, C.-M. 2003: Transforming growth factor-beta induces apoptosis in antigen-specific CD4+ T cells prepared for adoptive immunotherapy. Immunology Letters 86(1): 37-43

Lee, Y.C.G.; Lane, K.B.; Zoia, O.; Thompson, P.J.; Light, R.W.; Blackwell, T.S. 2003: Transforming growth factor-beta induces collagen synthesis without inducing IL-8 production in mesothelial cells. European Respiratory Journal 22(2): 197-202

Ravanti, L.; Häkkinen, L.; Larjava, H.; Saarialho-Kere, U.; Foschi, M.; Han, J.; Kähäri, V.M. 1999: Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. Journal of Biological Chemistry 274(52): 37292-37300

Wells, R.G.; Gilboa, L.; Sun, Y.; Liu, X.; Henis, Y.I.; Lodish, H.F. 1999: Transforming growth factor-beta induces formation of a dithiothreitol-resistant type I/Type II receptor complex in live cells. Journal of Biological Chemistry 274(9): 5716-5722

Cohen, P.; Nunn, S.E.; Peehl, D.M. 2000: Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: abnormalities in cells cultured from benign prostatic hyperplasia tissues. Journal of Endocrinology 164(2): 215-223

Kurisaki, A.; Kose, S.; Yoneda, Y.; Heldin, C.H.; Moustakas, A. 2001: Transforming growth factor-beta induces nuclear import of Smad3 in an importin-beta1 and Ran-dependent manner. Molecular Biology of the Cell 12(4): 1079-1091

Pilkington, M.F.; Sims, S.M.; Dixon, S.J. 2001: Transforming growth factor-beta induces osteoclast ruffling and chemotaxis: potential role in osteoclast recruitment. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 16(7): 1237-1247

Morrissey, J.; Guo, G.; Moridaira, K.; Fitzgerald, M.; McCracken, R.; Tolley, T.; Klahr, S. 2002: Transforming growth factor-beta induces renal epithelial jagged-1 expression in fibrotic disease. Journal of the American Society of Nephrology: Jasn 13(6): 1499-1508

Wang, W.-M.; Lee, S.; Steiglitz, B.M.; Scott, I.C.; Lebares, C.C.; Allen, M.L.; Brenner, M.C.; Takahara, K.; Greenspan, D.S. 2003: Transforming growth factor-beta induces secretion of activated ADAMTS-2. a procollagen IIi N-proteinase. Journal of Biological Chemistry 278(21): 19549-19557

Rousse, S.; Lallemand, F.; Montarras, D.; Pinset, C.; Mazars, A.; Prunier, C.; Atfi, A.; Dubois, C. 2001: Transforming growth factor-beta inhibition of insulin-like growth factor-binding protein-5 synthesis in skeletal muscle cells involves a c-Jun N-terminal kinase-dependent pathway. Journal of Biological Chemistry 276(50): 46961-46967

Tadlock, L.; Yamagiwa, Y.; Hawker, J.; Marienfeld, C.; Patel, T. 2003: Transforming growth factor-beta inhibition of proteasomal activity: a potential mechanism of growth arrest. American Journal of Physiology. Cell Physiology 285(2): C277-C285

Khan, S.A.; Mirsafian, M.; Howdeshell, K.; Dorrington, J.H. 1999: Transforming growth factor-beta inhibits DNA synthesis in immature rat Leydig cells in vitro. Molecular and Cellular Endocrinology 148(1-2): 21-28

Choy, L.; Derynck, R. 2003: Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. Journal of Biological Chemistry 278(11): 9609-9619

Kim, E.S.; Kim, R.S.; Ren, R.F.; Hawver, D.B.; Flanders, K.C. 1998: Transforming growth factor-beta inhibits apoptosis induced by beta-amyloid peptide fragment 25-35 in cultured neuronal cells. Brain Research. Molecular Brain Research 62(2): 122-130

Suberville, S.; Bellocq, A.; Peguillet, I.; Lantz, O.; Stordeur, P.; Fouqueray, B.; Baud, L. 2001: Transforming growth factor-beta inhibits interleukin-10 synthesis by human monocytic cells. European Cytokine Network 12(1): 141-146

Imai, K.; Takeshita, A.; Hanazawa, S. 2000: Transforming growth factor-beta inhibits lipopolysaccharide-stimulated expression of inflammatory cytokines in mouse macrophages through downregulation of activation protein 1 and CD14 receptor expression. Infection and Immunity 68(5): 2418-2423

Billiau, A.D.; Sefrioui, H.; Overbergh, L.; Rutgeerts, O.; Goebels, J.; Mathieu, C.; Waer, M. 2001: Transforming growth factor-beta inhibits lymphokine activated killer cytotoxicity of bone marrow cells: implications for the graft-versus-leukemia effect in irradiation allogeneic bone marrow chimeras. Transplantation 71(2): 292-299

Li, C.; Zhu, N.-L.; Tan, R.C.; Ballard, P.L.; Derynck, R.; Minoo, P. 2002: Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors. Journal of Biological Chemistry 277(41): 38399-38408

George, J.; Wang, S.S.; Sevcsik, A.M.; Sanicola, M.; Cate, R.L.; Koteliansky, V.E.; Bissell, D.M. 2000: Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform. American Journal of Pathology 156(1): 115-124

Baricos, W.H.; Cortez, S.L.; Deboisblanc, M.; Xin, S. 1999: Transforming growth factor-beta is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells. Journal of the American Society of Nephrology: Jasn 10(4): 790-795

Salm, S.N.; Koikawa, Y.; Ogilvie, V.; Tsujimura, A.; Coetzee, S.; Moscatelli, D.; Moore, E.; Lepor, H.; Shapiro, E.; Sun, T.T.; Wilson, E.L. 2000: Transforming growth factor-beta is an autocrine mitogen for a novel androgen-responsive murine prostatic smooth muscle cell line, PSMC1. Journal of Cellular Physiology 185(3): 416-424

Matsuo, K.; Ikizler, T.A.; Hoover, R.L.; Nakamoto, M.; Yasunaga, C.; Pupim, L.B.; Hakim, R.M. 2000: Transforming growth factor-beta is involved in the pathogenesis of dialysis-related amyloidosis. Kidney International 57(2): 697-708

Masi, L.; Malentacchi, C.; Campanacci, D.; Franchi, A. 2002: Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone. Virchows Archiv: An International Journal of Pathology 440(5): 491-497

Sloan, A.J.; Perry, H.; Matthews, J.B.; Smith, A.J. 2000: Transforming growth factor-beta isoform expression in mature human healthy and carious molar teeth. Histochemical Journal 32(4): 247-252

Wilson, H.M.; Minto, A.W.; Brown, P.A.; Erwig, L.P.; Rees, A.J. 2000: Transforming growth factor-beta isoforms and glomerular injury in nephrotoxic nephritis. Kidney International 57(6): 2434-2444

Tamura, M.; Fukaya, T.; Enomoto, A.; Murakami, T.; Uehara, S.; Yajima, A. 1999: Transforming growth factor-beta isoforms and receptors in endometriotic cysts of the human ovary. American Journal of Reproductive Immunology 42(3): 160-167

Kinbara, T.; Shirasaki, F.; Kawara, S.; Inagaki, Y.; de Crombrugghe, B.; Takehara, K. 2002: Transforming growth factor-beta isoforms differently stimulate proalpha2 (I) collagen gene expression during wound healing process in transgenic mice. Journal of Cellular Physiology 190(3): 375-381

Cuhaci, B.; Kumar, M.S.; Bloom, R.D.; Pratt, B.; Haussman, G.; Laskow, D.A.; Alidoost, M.; Grotkowski, C.; Cahill, K.; Butani, L.; Sturgill, B.C.; Pankewycz, O.G. 1999: Transforming growth factor-beta levels in human allograft chronic fibrosis correlate with rate of decline in renal function. Transplantation 68(6): 785-790

Tredget, E.E.; Wang, R.; Shen, Q.; Scott, P.G.; Ghahary, A. 2000: Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 20(2): 143-151

Tran, N.D.; Correale, J.; Schreiber, S.S.; Fisher, M. 1999: Transforming growth factor-beta mediates astrocyte-specific regulation of brain endothelial anticoagulant factors. Stroke 30(8): 1671-1678

Lutgens, E.; Gijbels, M.; Smook, M.; Heeringa, P.; Gotwals, P.; Koteliansky, V.E.; Daemen, M.J.A.P. 2002: Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arteriosclerosis Thrombosis and Vascular Biology 22(6): 975-982

Beck, P.L.; Rosenberg, I.M.; Xavier, R.J.; Koh, T.; Wong, Jée.F.; Podolsky, D.K. 2003: Transforming growth factor-beta mediates intestinal healing and susceptibility to injury in vitro and in vivo through epithelial cells. American Journal of Pathology 162(2): 597-608

Whiting, C.V.; Williams, A.M.; Claesson, M.H.; Bregenholt, S.; Reimann, J.; Bland, P.W. 2001: Transforming growth factor-beta messenger RNA and protein in murine colitis. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 49(6): 727-738

Ethier, J.-F.ço.; Farnworth, P.G.; Findlay, J.K.; Ooi, G.T. 2002: Transforming growth factor-beta modulates inhibin a bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan. Molecular Endocrinology 16(12): 2754-2763

Dalton, S.L.; Scharf, E.; Davey, G.; Assoian, R.K. 1999: Transforming growth factor-beta overrides the adhesion requirement for surface expression of alpha(5)beta(1) integrin in normal rat kidney fibroblasts. a necessary effect for induction of anchorage-independent growth. Journal of Biological Chemistry 274(42): 30139-30145

Cardillo, M.R.; Lazzereschi, D.; Gandini, O.; Di Silverio, F.; Colletta, G. 2001: Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma. Analytical and Quantitative Cytology and Histology 23(2): 109-117

Halliday, G.M.; Le, S. 2001: Transforming growth factor-beta produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin. International Immunology 13(9): 1147-1154

Sillett, H.K.; Cruickshank, S.M.; Southgate, J.; Trejdosiewicz, L.K. 2001: Transforming growth factor-beta promotes 'death by neglect' in post-activated human T cells. Immunology 102(3): 310-316

Yasuda, K.; Aoshiba, K.; Nagai, A. 2003: Transforming growth factor-beta promotes fibroblast apoptosis induced by H2O2. Experimental Lung Research 29(3): 123-134

Chen, T.; Triplett, J.; Dehner, B.; Hurst, B.; Colligan, B.; Pemberton, J.; Graff, J.R.; Carter, J.H. 2001: Transforming growth factor-beta receptor type i gene is frequently mutated in ovarian carcinomas. Cancer Research 61(12): 4679-4682

Goddard, I.; Bouras, M.; Keramidas, M.; Hendrick, J.C.; Feige, J.J.; Benahmed, M. 2000: Transforming growth factor-beta receptor types I and II in cultured porcine leydig cells: expression and hormonal regulation. Endocrinology 141(6): 2068-2074

Schultze-Mosgau, S.; Wehrhan, F.; Rödel, F.; Amann, K.; Radespiel-Tröger, M.; Grabenbauer, G.G. 2003: Transforming growth factor-beta receptor-Ii up-regulation during wound healing in previously irradiated graft beds in vivo. Wound Repair and Regeneration: Official Publication of the Wound Healing Society and the European Tissue Repair Society 11(4): 297-305

Wurthner, J.U.; Frank, D.B.; Felici, A.; Green, H.M.; Cao, Z.; Schneider, M.D.; McNally, J.G.; Lechleider, R.J.; Roberts, A.B. 2001: Transforming growth factor-beta receptor-associated protein 1 is a Smad4 chaperone. Journal of Biological Chemistry 276(22): 19495-19502

Watanabe, T.; Yamamoto, T.; Ikegaya, N.; Fujigaki, Y.; Suzuki, H.; Togawa, A.; Fukasawa, H.; Nagase, M.; Hishida, A. 2002: Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats. Journal of Pathology 198(3): 397-406

Yao, D.; Ehrlich, M.; Henis, Y.I.; Leof, E.B. 2002: Transforming growth factor-beta receptors interact with AP2 by direct binding to beta2 subunit. Molecular Biology of the Cell 13(11): 4001-4012

Fan, J.M.; Ng, Y.Y.; Hill, P.A.; Nikolic-Paterson, D.J.; Mu, W.; Atkins, R.C.; Lan, H.Y. 1999: Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney International 56(4): 1455-1467

Gonzalez, W.; Chen, Z.; Damon, D.H. 2001: Transforming growth factor-beta regulation of endothelin expression in rat vascular cell and organ cultures. Journal of Cardiovascular Pharmacology 37(2): 219-226

Valle, M.Teresa.; Porta, C.; Megiovanni, A.Maria.; Libener, R.; Mele, L.; Gaudino, G.; Strizzi, L.; Guida, R.; Toma, S.; Mutti, L. 2003: Transforming growth factor-beta released by PPD-presenting malignant mesothelioma cells inhibits interferon-gamma synthesis by an anti-PPD CD4+ T-cell clone. International Journal of Molecular Medicine 11(2): 161-167

Yuan, W.; Varga, J. 2001: Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. Journal of Biological Chemistry 276(42): 38502-38510

Harms, C.A.; Howard, K.E.; Wolf, J.C.; Smith, S.A.; Kennedy-Stoskopf, S. 2003: Transforming growth factor-beta response to mycobacterial infection in striped bass Morone saxatilis and hybrid tilapia Oreochromis spp. Veterinary Immunology and Immunopathology 95(3-4): 155-163

Dai, J.L.; Schutte, M.; Bansal, R.K.; Wilentz, R.E.; Sugar, A.Y.; Kern, S.E. 1999: Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells. Molecular Carcinogenesis 26(1): 37-43

Haneda, K.; Sano, K.; Tamura, G.; Shirota, H.; Ohkawara, Y.; Sato, T.; Habu, S.; Shirato, K. 1999: Transforming growth factor-beta secreted from CD4(+) T cells ameliorates antigen-induced eosinophilic inflammation. a novel high-dose tolerance in the trachea. American Journal of Respiratory Cell and Molecular Biology 21(2): 268-274

Cheng, J.; Grande, J.P. 2002: Transforming growth factor-beta signal transduction and progressive renal disease. Experimental Biology and Medicine 227(11): 943-956

Souchelnytskyi, S. 2002: Transforming growth factor-beta signaling and its role in cancer. Eksperimental'naya Onkologiya 24(1): 3-12

Verrecchia, F.; Mauviel, A. 2002: Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. Journal of Investigative Dermatology 118(2): 211-215

Goumans, M.J.; Zwijsen, A.; van Rooijen, M.A.; Huylebroeck, D.; Roelen, B.A.; Mummery, C.L. 1999: Transforming growth factor-beta signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice. Development 126(16): 3473-3483

Kucich, U.; Rosenbloom, J.C.; Abrams, W.R.; Rosenbloom, J. 2002: Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta, and p38. American Journal of Respiratory Cell and Molecular Biology 26(2): 183-188

Yonekura, A.; Osaki, M.; Hirota, Y.; Tsukazaki, T.; Miyazaki, Y.; Matsumoto, T.; Ohtsuru, A.; Namba, H.; Shindo, H.; Yamashita, S. 1999: Transforming growth factor-beta stimulates articular chondrocyte cell growth through p44/42 MAP kinase (ERK) activation. Endocrine Journal 46(4): 545-553

Palmer, G.; Guicheux, J.; Bonjour, J.P.; Caverzasio, J. 2000: Transforming growth factor-beta stimulates inorganic phosphate transport and expression of the type IIi phosphate transporter Glvr-1 in chondrogenic ATDC5 cells. Endocrinology 141(6): 2236-2243

Kakonen, S-Maria.; Selander, K.S.; Chirgwin, J.M.; Yin, J.Juan.; Burns, S.; Rankin, W.A.; Grubbs, B.G.; Dallas, M.; Cui, Y.; Guise, T.A. 2002: Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. Journal of Biological Chemistry 277(27): 24571-24578

Renner, U.; Lohrer, P.; Schaaf, L.; Feirer, M.; Schmitt, K.; Onofri, C.; Arzt, E.; Stalla, G.K. 2002: Transforming growth factor-beta stimulates vascular endothelial growth factor production by folliculostellate pituitary cells. Endocrinology 143(10): 3759-3765

Langermans, J.A.; Nibbering, P.H.; Van Vuren-Van Der Hulst, M.E.; Van Furth, R. 2001: Transforming growth factor-beta suppresses interferon-gamma-induced toxoplasmastatic activity in murine macrophages by inhibition of tumour necrosis factor-alpha production. Parasite Immunology 23(4): 169-175

Pawluczyk, I.Z.; Harris, K.P. 2001: Transforming growth factor-beta suppresses macrophage-induced mesangial cell fibronectin expression. Kidney International 60(2): 533-542

Harris, D.L.; Joyce, N.C. 1999: Transforming growth factor-beta suppresses proliferation of rabbit corneal endothelial cells in vitro. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 19(4): 327-334

Vaday, G.G.; Schor, H.; Rahat, M.A.; Lahat, N.; Lider, O. 2001: Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes. Journal of Leukocyte Biology 69(4): 613-621

Engel, J.D.; Kundu, S.D.; Yang, T.; Lang, S.; Goodwin, S.; Janulis, L.; Cho, J.S.; Chang, J.; Kim, S.J.; Lee, C. 1999: Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (Renca) cells. Urology 54(1): 164-170

Tada, Y.; Asahina, A.; Nakamura, K.; Miyazono, K.; Tomura, M.; Fujiwara, H.; Tamaki, K. 2001: Transforming growth factor-beta up-regulates CD40-engaged IL-12 production of mouse Langerhans cells. European Journal of Immunology 31(1): 294-300

Stahl, P.J.; Felsen, D. 2001: Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: implications for fibrosis in kidney disease. American Journal of Pathology 159(4): 1187-1192

Wolf, N.; Krohn, K.; Bieger, S.; Frödin, M.; Gammeltoft, S.; Krieglstein, K.; Unsicker, K. 1999: Transforming growth factor-beta, but not ciliary neurotrophic factor, inhibits DNA synthesis of adrenal medullary cells in vitro. Neuroscience 90(2): 629-641

Nomura, K.; Tada, H.; Kuboki, K.; Inokuchi, T. 2002: Transforming growth factor-beta-1 latency-associated peptide and soluble betaglycan prevent a glucose-induced increase in fibronectin production in cultured human mesangial cells. Nephron 91(4): 606-611

Jono, H.; Xu, H.; Kai, H.; Lim, D.J.; Kim, Y.S.; Feng, X-Hua.; Li, J-Dong. 2003: Transforming growth factor-beta-Smad signaling pathway negatively regulates nontypeable Haemophilus influenzae-induced MUC5AC mucin transcription via mitogen-activated protein kinase (MAPK) phosphatase-1-dependent inhibition of p38 MAPK. Journal of Biological Chemistry 278(30): 27811-27819

Ma, L.-J.; Yang, H.; Gaspert, A.; Carlesso, G.; Barty, M.M.; Davidson, J.M.; Sheppard, D.; Fogo, A.B. 2003: Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice. American Journal of Pathology 163(4): 1261-1273

Ryan, S.T.; Koteliansky, V.E.; Gotwals, P.J.; Lindner, V. 2003: Transforming growth factor-beta-dependent events in vascular remodeling following arterial injury. Journal of Vascular Research 40(1): 37-46

Bertone, S.; Schiavetti, F.; Bellomo, R.; Vitale, C.; Ponte, M.; Moretta, L.; Mingari, M.C. 1999: Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. European Journal of Immunology 29(1): 23-29

Fink, S.P.; Swinler, S.E.; Lutterbaugh, J.D.; Massagué, J.; Thiagalingam, S.; Kinzler, K.W.; Vogelstein, B.; Willson, J.K.; Markowitz, S. 2001: Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line. Cancer Research 61(1): 256-260

Edlund, S.; Landström, M.én.; Heldin, C.-H.; Aspenström, P. 2002: Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Molecular Biology of the Cell 13(3): 902-914

Karsdal, M.A.; Fjording, M.S.; Foged, N.T.; Delaissé, J.M.; Lochter, A. 2001: Transforming growth factor-beta-induced osteoblast elongation regulates osteoclastic bone resorption through a p38 mitogen-activated protein kinase- and matrix metalloproteinase-dependent pathway. Journal of Biological Chemistry 276(42): 39350-39358

Burton, T.; Liang, B.; Dibrov, A.; Amara, F. 2002: Transforming growth factor-beta-induced transcription of the Alzheimer beta-amyloid precursor protein gene involves interaction between the CTCF-complex and Smads. Biochemical and Biophysical Research Communications 295(3): 713-723

Menke, A.; Geerling, I.; Giehl, K.; Vogelmann, R.; Reinshagen, M.; Adler, G. 1999: Transforming growth factor-beta-induced upregulation of transforming growth factor-beta receptor expression in pancreatic regeneration. Biochimica et Biophysica Acta 1449(2): 178-185

Olsson, N.; Piek, E.; Sundström, M.; ten Dijke, P.; Nilsson, G. 2001: Transforming growth factor-beta-mediated mast cell migration depends on mitogen-activated protein kinase activity. Cellular Signalling 13(7): 483-490

Rich, J.N.; Zhang, M.; Datto, M.B.; Bigner, D.D.; Wang, X.F. 1999: Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines. Journal of Biological Chemistry 274(49): 35053-35058

Kester, H.A.; Blanchetot, C.; den Hertog, J.; van der Saag, P.T.; van der Burg, B. 1999: Transforming growth factor-beta-stimulated clone-22 is a member of a family of leucine zipper proteins that can homo- and heterodimerize and has transcriptional repressor activity. Journal of Biological Chemistry 274(39): 27439-27447

Folger, P.A.; Zekaria, D.; Grotendorst, G.; Masur, S.K. 2001: Transforming growth factor-beta-stimulated connective tissue growth factor expression during corneal myofibroblast differentiation. IOVS Investigative Ophthalmology and Visual Science 42(11): 2534-2541

Kanai, H.; Tanaka, T.; Aihara, Y.; Takeda, S.; Kawabata, M.; Miyazono, K.; Nagai, R.; Kurabayashi, M. 2001: Transforming growth factor-beta/Smads signaling induces transcription of the cell type-restricted ankyrin repeat protein CARP gene through CAGA motif in vascular smooth muscle cells. Circulation Research 88(1): 30-36

Massey, H.M.; Scopes, J.; Horton, M.A.; Flanagan, A.M. 2001: Transforming growth factor-beta1 (TGF-beta) stimulates the osteoclast-forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironment. Bone 28(6): 577-582

Edlund, S.; Bu, S.; Schuster, N.; Aspenström, P.; Heuchel, R.; Heldin, N-Erik.; ten Dijke, P.; Heldin, C-Henrik.; Landström, Méne. 2003: Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3. Molecular Biology of the Cell 14(2): 529-544

Han, J.; Hajjar, D.P.; Tauras, J.M.; Feng, J.; Gotto, A.M.; Nicholson, A.C. 2000: Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. Journal of Biological Chemistry 275(2): 1241-1246

Sakamaki, S.; Hirayama, Y.; Matsunaga, T.; Kuroda, H.; Kusakabe, T.; Akiyama, T.; Konuma, Y.; Sasaki, K.; Tsuji, N.; Okamoto, T.; Kobune, M.; Kogawa, K.; Kato, J.; Takimoto, R.; Koyama, R.; Niitsu, Y. 1999: Transforming growth factor-beta1 (TGF-beta1) induces thrombopoietin from bone marrow stromal cells, which stimulates the expression of TGF-beta receptor on megakaryocytes and, in turn, renders them susceptible to suppression by TGF-beta itself with high specificity. Blood 94(6): 1961-1970

Nehra, A.; Gettman, M.T.; Nugent, M.; Bostwick, D.G.; Barrett, D.M.; Goldstein, I.; Krane, R.J.; Moreland, R.B. 1999: Transforming growth factor-beta1 (TGF-beta1) is sufficient to induce fibrosis of rabbit corpus cavernosum in vivo. Journal of Urology 162(3 Pt 1): 910-915

Docherty, N.G.; Pérez-Barriocanal, F.; Balboa, N.E.; López-Novoa, Jé.M. 2002: Transforming growth factor-beta1 (TGF-beta1): a potential recovery signal in the post-ischemic kidney. Renal Failure 24(4): 391-406

Andoh, A.; Shimada, M.; Takaya, H.; Hata, K.; Fujiyama, Y.; Bamba, T. 2000: Transforming growth factor-beta1 acts as a potent inhibitor of complement C3 biosynthesis in human pancreatic cancer cell lines. Pancreas 20(2): 138-145

Lin, M.; Overgaard, S.; Glerup, H.; Søballe, K.; Bünger, C. 2001: Transforming growth factor-beta1 adsorbed to tricalciumphosphate coated implants increases peri-implant bone remodeling. Biomaterials 22(3): 189-193

Shiba, H.; Uchida, Y.; Kamihagi, K.; Sakata, M.; Fujita, T.; Nakamura, S.; Takemoto, T.; Kato, Y.; Kurihara, H. 2001: Transforming growth factor-beta1 and basic fibroblast growth factor modulate osteocalcin and osteonectin/SPARC syntheses in vitamin-D-activated pulp cells. Journal of Dental Research 80(7): 1653-1659

Cai, F.; Campana, W.M.; Tomlinson, D.R.; Fernyhough, P. 1999: Transforming growth factor-beta1 and glial growth factor 2 reduce neurotrophin-3 mRNA expression in cultured Schwann cells via a cAMP-dependent pathway. Brain Research. Molecular Brain Research 71(2): 256-264

Goumenos, D.S.; Tsamandas, A.C.; Oldroyd, S.; Sotsiou, F.; Tsakas, S.; Petropoulou, C.; Bonikos, D.; El Nahas, A.M.; Vlachojannis, J.G. 2001: Transforming growth factor-beta(1) and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease. Nephron 87(3): 240-248

Wikström, P.; Bergh, A.; Damber, J.E. 2000: Transforming growth factor-beta1 and prostate cancer. Scandinavian Journal of Urology and Nephrology 34(2): 85-94

Shimabukuro, T.; Ohmoto, Y.; Naito, K. 2003: Transforming growth factor-beta1 and renal cell cancer: cell growth, mRNA expression and protein production of cytokines. Journal of Urology 169(5): 1865-1869

Langham, R.G.; Egan, M.K.; Dowling, J.P.; Gilbert, R.E.; Thomson, N.M. 2001: Transforming growth factor-beta1 and tumor growth factor-beta-inducible gene-H3 in nonrenal transplant cyclosporine nephropathy. Transplantation 72(11): 1826-1829

Trompezinski, S.; Pernet, I.; Mayoux, C.; Schmitt, D.; Viac, J. 2000: Transforming growth factor-beta1 and ultraviolet A1 radiation increase production of vascular endothelial growth factor but not endothelin-1 in human dermal fibroblasts. British Journal of Dermatology 143(3): 539-545

Isaka, Y.; Tsujie, M.; Ando, Y.; Nakamura, H.; Kaneda, Y.; Imai, E.; Hori, M. 2000: Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney International 58(5): 1885-1892

Docagne, F.; Nicole, O.; Marti, H.H.; MacKenzie, E.T.; Buisson, A.; Vivien, D. 1999: Transforming growth factor-beta1 as a regulator of the serpins/t-PA axis in cerebral ischemia. FASEB Journal 13(11): 1315-1324

Song, B-Cheol.; Chung, Y-Hwa.; Kim, J.A.; Choi, W-Beom.; Suh, D.Dae.; Pyo, S.Il.; Shin, J.Woo.; Lee, H.Chu.; Lee, Y.Sang.; Suh, D.Jin. 2002: Transforming growth factor-beta1 as a useful serologic marker of small hepatocellular carcinoma. Cancer 94(1): 175-180

Suzuki, M.; Harashima, A.; Okochi, A.; Yamamoto, M.; Matsuo, Y.; Motoda, R.; Yoshioka, T.; Orita, K. 2002: Transforming growth factor-beta(1) augments granulocyte-macrophage colony-stimulating factor-induced proliferation of umbilical cord blood CD34(+) cells with an associated tyrosine phosphorylation of STAT5. Experimental Hematology 30(10): 1132-1138

Chang, N-Shan. 2002: Transforming growth factor-beta1 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts. Bmc Cell Biology 3: 8

Pierelli, L.; Marone, M.; Bonanno, G.; Rutella, S.; de Ritis, D.; Mancuso, S.; Leone, G.; Scambia, G. 2002: Transforming growth factor-beta1 causes transcriptional activation of CD34 and preserves haematopoietic stem/progenitor cell activity. British Journal of Haematology 118(2): 627-637

Wright, N.; de Lera, T.Laín.; García-Moruja, C.; Lillo, R.; García-Sánchez, Félix.; Caruz, A.; Teixidó, J. 2003: Transforming growth factor-beta1 down-regulates expression of chemokine stromal cell-derived factor-1: functional consequences in cell migration and adhesion. Blood 102(6): 1978-1984

Shen, H.; Huang, G.; Hadi, M.; Choy, P.; Zhang, M.; Minuk, G.Y.; Chen, Y.; Gong, Y. 2003: Transforming growth factor-beta1 downregulation of Smad1 gene expression in rat hepatic stellate cells. American Journal of Physiology. Gastrointestinal and Liver Physiology 285(3): G539-G546

Sheng, H.; Shao, J.; Dixon, D.A.; Williams, C.S.; Prescott, S.M.; DuBois, R.N.; Beauchamp, R.D. 2000: Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. Journal of Biological Chemistry 275(9): 6628-6635

Sometani, A.; Kataoka, H.; Nitta, A.; Fukumitsu, H.; Nomoto, H.; Furukawa, S. 2001: Transforming growth factor-beta1 enhances expression of brain-derived neurotrophic factor and its receptor, TrkB, in neurons cultured from rat cerebral cortex. Journal of Neuroscience Research 66(3): 369-376

Matagrano, L.B.; Magida, J.A.; McGee, D.W. 2003: Transforming growth factor-beta1 enhances the secretion of monocyte chemoattractant protein-1 by the IEC-18 intestinal epithelial cell line. In Vitro Cellular and Developmental Biology. Animal 39(3-4): 183-186

Song, Q.H.; Singh, R.P.; Richardson, T.P.; Nugent, M.A.; Trinkaus-Randall, V. 2000: Transforming growth factor-beta1 expression in cultured corneal fibroblasts in response to injury. Journal of Cellular Biochemistry 77(2): 186-199

Sanderson, J.E.; Lai, K.B.; Shum, I.O.; Wei, S.; Chow, L.T. 2001: Transforming growth factor-beta(1) expression in dilated cardiomyopathy. Heart 86(6): 701-708

Cardillo, M.R.; Filipo, R.; Monini, S.; Aliotta, N.; Barbara, M. 1999: Transforming growth factor-beta1 expression in human acoustic neuroma. American Journal of Otology 20(1): 65-68

Wu, L.; Xia, Y.P.; Roth, S.I.; Gruskin, E.; Mustoe, T.A. 1999: Transforming growth factor-beta1 fails to stimulate wound healing and impairs its signal transduction in an aged ischemic ulcer model: importance of oxygen and age. American Journal of Pathology 154(1): 301-309

Chen, Y.L.; Wu, H.W.; Jiang, M.J. 2000: Transforming growth factor-beta1 gene and protein expression associated with atherogenesis of cholesterol-fed rabbits. Histology and Histopathology 15(2): 421-428

Bertoldo, F.; D'Agruma, L.; Furlan, F.; Colapietro, F.; Lorenzi, M.T.; Maiorano, N.; Iolascon, A.; Zelante, L.; Locascio, V.; Gasparini, P. 2000: Transforming growth factor-beta1 gene polymorphism, bone turnover, and bone mass in Italian postmenopausal women. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 15(4): 634-639

Xaubet, A.; Marin-Arguedas, A.; Lario, S.; Ancochea, J.; Morell, F.; Ruiz-Manzano, J.; Rodriguez-Becerra, E.; Rodriguez-Arias, J.M.; Inigo, P.; Sanz, S.; Campistol, J.M.; Mullol, J.; Picado, C. 2003: Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 168(4): 431-435

Ostlund, E.; Tally, M.; Fried, G. 2002: Transforming growth factor-beta1 in fetal serum correlates with insulin-like growth factor-I and fetal growth. Obstetrics and Gynecology 100(3): 567-573

Saarinen, K.M.; Vaarala, O.; Klemetti, P.; Savilahti, E. 1999: Transforming growth factor-beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology 104(5): 1093-1098

Salez, F.; Gosset, P.; Copin, M.C.; Lamblin Degros, C.; Tonnel, A.B.; Wallaert, B. 1998: Transforming growth factor-beta1 in sarcoidosis. European Respiratory Journal 12(4): 913-919

Ghio, M.; Ottonello, L.; Contini, P.; Amelotti, M.; Mazzei, C.; Indiveri, F.; Puppo, F.; Dallegri, F. 2003: Transforming growth factor-beta1 in supernatants from stored red blood cells inhibits neutrophil locomotion. Blood 102(3): 1100-1107

Flood, C.; Akinwunmi, J.; Lagord, C.; Daniel, M.; Berry, M.; Jackowski, A.; Logan, A. 2001: Transforming growth factor-beta1 in the cerebrospinal fluid of patients with subarachnoid hemorrhage: titers derived from exogenous and endogenous sources. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 21(2): 157-162

Goumenos, D.S.; Tsakas, S.; El Nahas, A.Meguid.; Alexandri, S.; Oldroyd, S.; Kalliakmani, P.; Vlachojannis, J.G. 2002: Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 17(12): 2145-2152

Blom, E.J.; Klein-Nulend, J.; Klein, C.P.; Kurashina, K.; van Waas, M.A.; Burger, E.H. 2000: Transforming growth factor-beta1 incorporated during setting in calcium phosphate cement stimulates bone cell differentiation in vitro. Journal of Biomedical Materials Research 50(1): 67-74

Blom, E.J.; Klein-Nulend, J.; Wolke, J.G.C.; Kurashina, K.; van Waas, M.A.J.; Burger, E.H. 2002: Transforming growth factor-beta1 incorporation in an alpha-tricalcium phosphate/dicalcium phosphate dihydrate/tetracalcium phosphate monoxide cement: release characteristics and physicochemical properties. Biomaterials 23(4): 1261-1268

Sharma, R.; Khanna, A.; Sharma, M.; Savin, V.J. 2000: Transforming growth factor-beta1 increases albumin permeability of isolated rat glomeruli via hydroxyl radicals. Kidney International 58(1): 131-136

Murakami, T.; Yamamoto, M.; Ono, K.; Nishikawa, M.; Nagata, N.; Motoyoshi, K.; Akatsu, T. 1998: Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. Biochemical and Biophysical Research Communications 252(3): 747-752

Berking, C.; Takemoto, R.; Schaider, H.; Showe, L.; Satyamoorthy, K.; Robbins, P.; Herlyn, M. 2001: Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling. Cancer Research 61(22): 8306-8316

Minami, M.; Kume, N.; Kataoka, H.; Morimoto, M.; Hayashida, K.; Sawamura, T.; Masaki, T.; Kita, T. 2000: Transforming growth factor-beta(1) increases the expression of lectin-like oxidized low-density lipoprotein receptor-1. Biochemical and Biophysical Research Communications 272(2): 357-361

Xiao, M.; Oppenlander, B.K.; Dooley, D.C. 2001: Transforming growth factor-beta(1) induces apoptosis in CD34(+)CD38(-/low) cells that express Bcl-2 at a low level. Experimental Hematology 29(9): 1098-1108

Freathy, C.; Brown, D.G.; Roberts, R.A.; Cain, K. 2000: Transforming growth factor-beta1 induces apoptosis in rat FaO hepatoma cells via cytochrome c release and oligomerization of Apaf-1 to form a apprx700-kd apoptosome caspase-processing complex. Hepatology 32(4 Pt 1): 750-760

Hyman, K.M.; Seghezzi, G.; Pintucci, G.; Stellari, G.; Kim, J.Hyun.; Grossi, E.A.; Galloway, A.C.; Mignatti, P. 2002: Transforming growth factor-beta1 induces apoptosis in vascular endothelial cells by activation of mitogen-activated protein kinase. Surgery 132(2): 173-179

Hishikawa, K.; Nakaki, T.; Fujii, T. 1999: Transforming growth factor-beta(1) induces apoptosis via connective tissue growth factor in human aortic smooth muscle cells. European Journal of Pharmacology 385(2-3): 287-290

Rodríguez-Barbero, A.; Obreo, J.; Yuste, L.; Montero, J.C.; Rodríguez-Peña, A.; Pandiella, A.; Bernabéu, C.; López-Novoa, J.M. 2002: Transforming growth factor-beta1 induces collagen synthesis and accumulation via p38 mitogen-activated protein kinase (MAPK) pathway in cultured L(6)E(9) myoblasts. Febs Letters 513(2-3): 282-288

Löhr, M.; Schmidt, C.; Ringel, J.; Kluth, M.; Müller, P.; Nizze, H.; Jesnowski, R. 2001: Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Research 61(2): 550-555

Lee, S.D.; Lee, D.S.; Chun, Y.G.; Paik, S.H.; Kim, W.S.; Kim, D.S.; Kim, W.D.; Tuder, R.M.; Voelkel, N.F. 2000: Transforming growth factor-beta1 induces endothelin-1 in a bovine pulmonary artery endothelial cell line and rat lungs via cAMP. Pulmonary Pharmacology and Therapeutics 13(6): 257-265

Samson, C.M.; Schrum, L.W.; Bird, M.A.; Lange, P.A.; Brenner, D.A.; Rippe, R.A.; Behrns, K.E. 2002: Transforming growth factor-beta1 induces hepatocyte apoptosis by a c-Jun independent mechanism. Surgery 132(3): 441-449

Eickelberg, O.; Pansky, A.; Mussmann, R.; Bihl, M.; Tamm, M.; Hildebrand, P.; Perruchoud, A.P.; Roth, M. 1999: Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts. Journal of Biological Chemistry 274(18): 12933-12938

Pacherník, J.; Soucek, K.; Hampl, A.; Hofmanová, J.; Kozubík, A. 2001: Transforming growth factor-beta1 induces junB mRNA accumulation, G1-phase arrest, and pRb dephosphorylation in human leukemia HL-60 cells. Folia Biologica 47(1): 32-35

Hashimoto, S.; Gon, Y.; Takeshita, I.; Matsumoto, K.; Maruoka, S.; Horie, T. 2001: Transforming growth Factor-beta1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway. American Journal of Respiratory and Critical Care Medicine 163(1): 152-157

Morgan, T.E.; Rozovsky, I.; Sarkar, D.K.; Young-Chan, C.S.; Nichols, N.R.; Laping, N.J.; Finch, C.E. 2000: Transforming growth factor-beta1 induces transforming growth factor-beta1 and transforming growth factor-beta receptor messenger RNAs and reduces complement C1qB messenger RNA in rat brain microglia. Neuroscience 101(2): 313-321

Mostert, V.; Dreher, I.; Kohrle, J.; Abel, J. 1999: Transforming growth factor-beta1 inhibits expression of selenoprotein P in cultured human liver cells. Febs Letters 460(1): 23-26

Argmann, C.A.; Van Den Diepstraten, C.H.; Sawyez, C.G.; Edwards, J.Y.; Hegele, R.A.; Wolfe, B.M.; Huff, M.W. 2001: Transforming growth factor-beta1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. Arteriosclerosis Thrombosis and Vascular Biology 21(12): 2011-2018

Farrow, K.N.; Gutierrez-Hartmann, A. 1999: Transforming growth factor-beta1 inhibits rat prolactin promoter activity in GH4 neuroendocrine cells. Dna and Cell Biology 18(11): 863-873

Matsumoto, K.; Kanmatsuse, K. 2001: Transforming growth factor-beta1 inhibits vascular permeability factor release by T cells in normal subjects and in patients with minimal-change nephrotic syndrome. Nephron 87(2): 111-117

Kalina, U.; Koschmieder, S.; Hofmann, W.K.; Wagner, S.; Kauschat, D.; Hoelzer, D.; Ottmann, O.G. 2001: Transforming growth factor-beta1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells. Experimental Hematology 29(5): 602-608

Derman, S.G.; Kol, S.; Ben-Shlomo, I.; Resnick, C.E.; Rohan, R.M.; Adashi, E.Y. 1999: Transforming growth factor-beta1 is a potent inhibitor of interleukin-1beta action in whole ovarian dispersates. Journal of Endocrinology 160(3): 415-423

Defacque, H.; Piquemal, D.; Basset, A.; Marti, J.; Commes, T. 1999: Transforming growth factor-beta1 is an autocrine mediator of U937 cell growth arrest and differentiation induced by vitamin D3 and retinoids. Journal of Cellular Physiology 178(1): 109-119

Tsutsumi, S.; Tomisato, W.; Hoshino, T.; Tsuchiya, T.; Mizushima, T. 2002: Transforming growth factor-beta1 is responsible for maturation-dependent spontaneous apoptosis of cultured gastric pit cells. Experimental Biology and Medicine 227(6): 402-411

Abbate, M.; Zoja, C.; Morigi, M.; Rottoli, D.; Angioletti, S.; Tomasoni, S.; Zanchi, C.; Longaretti, L.; Donadelli, R.; Remuzzi, G. 2002: Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis. American Journal of Pathology 161(6): 2179-2193

Hasegawa, Y.; Takanashi, S.; Kanehira, Y.; Tsushima, T.; Imai, T.; Okumura, K. 2001: Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer 91(5): 964-971

Porreca, E.; Di Febbo, C.; Vitacolonna, E.; Baccante, G.; Di Castelnuovo, A.; Angelini, A.; Febo, F.; Di Nisio, M.; Cuccurullo, F. 2002: Transforming growth factor-beta1 levels in hypertensive patients: association with body mass index and leptin. American Journal of Hypertension 15(9): 759-765

Taniguchi, Y.; Yorioka, N.; Yamashita, K.; Masaki, T.; Yamakido, M. 1999: Transforming growth factor-beta1 may be involved in shunt obstruction in patients on chronic hemodialysis. Nephron 81(1): 102-105

Ewan, K.B.; Henshall-Powell, R.L.; Ravani, S.A.; Pajares, M.Jose.; Arteaga, C.; Warters, R.; Akhurst, R.J.; Barcellos-Hoff, M.Helen.; Barcellos-Hoff, M.H. 2002: Transforming growth factor-beta1 mediates cellular response to DNA damage in situ. Cancer Research 62(20): 5627-5631

Wright, S.H.; Brown, J.; Knight, P.A.; Thornton, E.M.; Kilshaw, P.J.; Miller, H.R.P. 2002: Transforming growth factor-beta1 mediates coexpression of the integrin subunit alphaE and the chymase mouse mast cell protease-1 during the early differentiation of bone marrow-derived mucosal mast cell homologues. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 32(2): 315-324

Bhowmick, N.A.; Ghiassi, M.; Bakin, A.; Aakre, M.; Lundquist, C.A.; Engel, M.E.; Arteaga, C.L.; Moses, H.L. 2001: Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Molecular Biology of the Cell 12(1): 27-36

Bouillier, H.; Samain, E.; Miserey, S.; Perret, C.; Renaud, J.F.; Safar, M.; Dagher, G. 2000: Transforming growth factor-beta1 modulates angiotensin II-induced calcium release in vascular smooth muscle cells from spontaneously hypertensive rats. Journal of Hypertension 18(6): 733-742

Rout, U.K.; Saed, G.M.; Diamond, M.P. 2002: Transforming growth factor-beta1 modulates expression of adhesion and cytoskeletal proteins in human peritoneal fibroblasts. Fertility and Sterility 78(1): 154-161

Santibáñez, J.Francisco.; Guerrero, J.; Quintanilla, M.; Fabra, A.; Martínez, J. 2002: Transforming growth factor-beta1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes. Biochemical and Biophysical Research Communications 296(2): 267-273

Chen, H.; Li, D.; Saldeen, T.; Mehta, J.L. 2001: Transforming growth factor-beta(1) modulates oxidatively modified LDL-induced expression of adhesion molecules: role of LOX-1. Circulation Research 89(12): 1155-1160

Saadeh, P.B.; Mehrara, B.J.; Steinbrech, D.S.; Dudziak, M.E.; Greenwald, J.A.; Luchs, J.S.; Spector, J.A.; Ueno, H.; Gittes, G.K.; Longaker, M.T. 1999: Transforming growth factor-beta1 modulates the expression of vascular endothelial growth factor by osteoblasts. American Journal of Physiology 277(4): C628-C637

Thyagarajan, T.; Kulkarni, A.B. 2002: Transforming growth factor-beta1 negatively regulates crystallin expression in teeth. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 17(9): 1710-1717

Zhang, Y.; Zhang, Y.Y.; Ogata, M.; Chen, P.; Harada, A.; Hashimoto, S.; Matsushima, K. 1999: Transforming growth factor-beta1 polarizes murine hematopoietic progenitor cells to generate Langerhans cell-like dendritic cells through a monocyte/macrophage differentiation pathway. Blood 93(4): 1208-1220

Planchon, S.; Fiocchi, C.; Takafuji, V.; Roche, J.K. 1999: Transforming growth factor-beta1 preserves epithelial barrier function: identification of receptors, biochemical intermediates, and cytokine antagonists. Journal of Cellular Physiology 181(1): 55-66

Hirashima, Y.; Kobayashi, H.; Suzuki, M.; Tanaka, Y.; Kanayama, N.; Terao, T. 2003: Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells. Journal of Biological Chemistry 278(29): 26793-26802

Fujimoto, K.; Sheng, H.; Shao, J.; Beauchamp, R.D. 2001: Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells. Experimental Cell Research 266(2): 239-249

Vaughan, M.B.; Howard, E.W.; Tomasek, J.J. 2000: Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. Experimental Cell Research 257(1): 180-189

Park, D.Y.; Suh, K.S. 1999: Transforming growth factor-beta1 protein, proliferation and apoptosis of oval cells in acetylaminofluorene-induced rat liver regeneration. Journal of Korean Medical Science 14(5): 531-538

Bouzahzah, B.; Fu, M.; Iavarone, A.; Factor, V.M.; Thorgeirsson, S.S.; Pestell, R.G. 2000: Transforming growth factor-beta1 recruits histone deacetylase 1 to a p130 repressor complex in transgenic mice in vivo. Cancer Research 60(16): 4531-4537

Tse, W.K.; Whitley, G.St.J.; Cartwright, J.E. 2002: Transforming growth factor-beta1 regulates hepatocyte growth factor-induced trophoblast motility and invasion. Placenta 23(10): 699-705

Rosado, E.; Schwartz, Z.; Sylvia, V.L.; Dean, D.D.; Boyan, B.D. 2002: Transforming growth factor-beta1 regulation of growth zone chondrocytes is mediated by multiple interacting pathways. Biochimica et Biophysica Acta 1590(1-3): 1-15

Sylvia, V.L.; Schwartz, Z.; Dean, D.D.; Boyan, B.D. 2000: Transforming growth factor-beta1 regulation of resting zone chondrocytes is mediated by two separate but interacting pathways. Biochimica et Biophysica Acta 1496(2-3): 311-324

Kumar, A.S.; Gonzales, L.W.; Ballard, P.L. 2000: Transforming growth factor-beta(1) regulation of surfactant protein B gene expression is mediated by protein kinase-dependent intracellular translocation of thyroid transcription factor-1 and hepatocyte nuclear factor 3. Biochimica et Biophysica Acta 1492(1): 45-55

Tatsumi, M.; Kishi, Y.; Miyata, T.; Numano, F. 2000: Transforming growth factor-beta(1) restores antiplatelet function of endothelial cells exposed to anoxia-reoxygenation injury. Thrombosis Research 98(5): 451-459

Durante, W.; Liao, L.; Reyna, S.V.; Peyton, K.J.; Schafer, A.I. 2001: Transforming growth factor-beta(1) stimulates L-arginine transport and metabolism in vascular smooth muscle cells: role in polyamine and collagen synthesis. Circulation 103(8): 1121-1127

Kveiborg, M.; Flyvbjerg, A.; Eriksen, E.F.; Kassem, M. 2001: Transforming growth factor-beta1 stimulates the production of insulin-like growth factor-i and insulin-like growth factor-binding protein-3 in human bone marrow stromal osteoblast progenitors. Journal of Endocrinology 169(3): 549-561

Neubauer, K.; Krüger, M.; Quondamatteo, F.; Knittel, T.; Saile, B.; Ramadori, G. 1999: Transforming growth factor-beta1 stimulates the synthesis of basement membrane proteins laminin, collagen type IV and entactin in rat liver sinusoidal endothelial cells. Journal of Hepatology 31(4): 692-702

Sumiyoshi, K.; Nakao, A.; Ushio, H.; Mitsuishi, K.; Okumura, K.; Tsuboi, R.; Ra, C.; Ogawa, H. 2002: Transforming growth factor-beta1 suppresses atopic dermatitis-like skin lesions in NC/Nga mice. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 32(2): 309-314

Bönig, H.; Banning, U.; Hannen, M.; Kim, Y.M.; Verheyen, J.; Mauz-Körholz, C.; Körholz, D. 1999: Transforming growth factor-beta1 suppresses interleukin-15-mediated interferon-gamma production in human T lymphocytes. Scandinavian Journal of Immunology 50(6): 612-618

Giannelli, G.; Fransvea, E.; Marinosci, F.; Bergamini, C.; Colucci, S.; Schiraldi, O.; Antonaci, S. 2002: Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin. American Journal of Pathology 161(1): 183-193

Robson, C.N.; Gnanapragasam, V.; Byrne, R.L.; Collins, A.T.; Neal, D.E. 1999: Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium. Journal of Endocrinology 160(2): 257-266

Schilling, B.; Yeh, J. 2000: Transforming growth factor-beta(1), -beta(2), -beta(3) and their type i and Ii receptors in human term placenta. Gynecologic and Obstetric Investigation 50(1): 19-23

Cordeiro, M.F.; Reichel, M.B.; Gay, J.A.; D'Esposita, F.; Alexander, R.A.; Khaw, P.T. 1999: Transforming growth factor-beta1, -beta2, and -beta3 in vivo: effects on normal and mitomycin C-modulated conjunctival scarring. IOVS Investigative Ophthalmology and Visual Science 40(9): 1975-1982

Schiött, A.; Widegren, B.; Sjögren, H.O.; Lindvall, M. 1999: Transforming growth factor-beta1, a strong costimulator of rat T-cell activation promoting a shift towards a Th2-like cytokine profile. Immunology Letters 67(2): 131-139

Buenemann, C.L.; Willy, C.; Buchmann, A.; Schmiechen, A.; Schwarz, M. 2001: Transforming growth factor-beta1-induced Smad signaling, cell-cycle arrest and apoptosis in hepatoma cells. Carcinogenesis 22(3): 447-452

Sintich, S.M.; Lamm, M.L.; Sensibar, J.A.; Lee, C. 1999: Transforming growth factor-beta1-induced proliferation of the prostate cancer cell line, TSU-Pr1: the role of platelet-derived growth factor. Endocrinology 140(8): 3411-3415

Lesné, S.; Blanchet, S.; Docagne, F.; Liot, Géraldine.; Plawinski, L.; MacKenzie, E.T.; Auffray, C.; Buisson, A.; Piétu, Géve.; Vivien, D. 2002: Transforming growth factor-beta1-modulated cerebral gene expression. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 22(9): 1114-1123

Whitelaw, A.; Christie, S.; Pople, I. 1999: Transforming growth factor-beta1: a possible signal molecule for posthemorrhagic hydrocephalus?. Pediatric Research 46(5): 576-580

Petratos, P.B.; Felsen, D.; Trierweiler, G.; Pratt, B.; McPherson, J.M.; Poppas, D.P. 2002: Transforming growth factor-beta2 (TGF-beta2) reverses the inhibitory effects of fibrin sealant on cutaneous wound repair in the pig. Wound Repair and Regeneration: Official Publication of the Wound Healing Society and the European Tissue Repair Society 10(4): 252-258

Hill, C.; Flyvbjerg, A.; Rasch, R.; Bak, M.; Logan, A. 2001: Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney. Journal of Endocrinology 170(3): 647-651

Gary Lee, Y.C.; Teixeira, L.R.; Devin, C.J.; Vaz, M.A.; Vargas, F.S.; Thompson, P.J.; Lane, K.B.; Light, R.W. 2001: Transforming growth factor-beta2 induces pleurodesis significantly faster than talc. American Journal of Respiratory and Critical Care Medicine 163(3 Part 1): 640-644

Murakami, N.; McLennan, I.S.; Nonaka, I.; Koishi, K.; Baker, C.; Hammond-Tooke, G. 1999: Transforming growth factor-beta2 is elevated in skeletal muscle disorders. Muscle and Nerve 22(7): 889-898

Inatani, M.; Tanihara, H.; Katsuta, H.; Honjo, M.; Kido, N.; Honda, Y. 2001: Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefe's Archive for Clinical and Experimental Ophthalmology 239(2): 109-113

Zhang, R.; Supowit, S.C.; Hou, X.; Simmons, D.J. 1999: Transforming growth factor-beta2 mRNA level in unloaded bone analyzed by quantitative in situ hybridization. Calcified Tissue International 64(6): 522-526

Konrad, L.; Albrecht, M.; Renneberg, H.; Aumüller, G. 2000: Transforming growth factor-beta2 mediates mesenchymal-epithelial interactions of testicular somatic cells. Endocrinology 141(10): 3679-3686

Arici, A.; Sozen, I. 2000: Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertility and Sterility 73(5): 1006-1011

Lui, W.Y.; Lee, W.M.; Cheng, C.Y. 2001: Transforming growth factor-beta3 perturbs the inter-Sertoli tight junction permeability barrier in vitro possibly mediated via its effects on occludin, zonula occludens-1, and claudin-11. Endocrinology 142(5): 1865-1877

Hentges, S.; Boyadjieva, N.; Sarkar, D.K. 2000: Transforming growth factor-beta3 stimulates lactotrope cell growth by increasing basic fibroblast growth factor from folliculo-stellate cells. Endocrinology 141(3): 859-867

Kondaiah, P.; Taira, M.; Vempati, U.D.; Dawid, I.B. 2000: Transforming growth factor-beta5 expression during early development of Xenopus laevis. Mechanisms of Development 95(1-2): 207-209

Lutgens, E.; Daemen, M.J. 2001: Transforming growth factor-beta: a local or systemic mediator of plaque stability?. Circulation Research 89(10): 853-855

Dhandapani, K.M.; Brann, D.W. 2003: Transforming growth factor-beta: a neuroprotective factor in cerebral ischemia. Cell Biochemistry and Biophysics 39(1): 13-22

Shukla, A.; Meisler, N.; Cutroneo, K.R. 1999: Transforming growth factor-beta: Crossroad of glucocorticoid and bleomycin regulation of collagen synthesis in lung fibroblasts. Wound Repair and Regeneration 7(3): 133-140

Fortunel, N.O.; Hatzfeld, A.; Hatzfeld, J.A. 2000: Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis. Blood 96(6): 2022-2036

Syrris, P.; Carter, N.D.; Metcalfe, J.C.; Kemp, P.R.; Grainger, D.J.; Kaski, J.C.; Crossman, D.C.; Francis, S.E.; Gunn, J.; Jeffery, S.; Heathcote, K. 1998: Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clinical Science 95(6): 659-667

Jeziorska, M. 2001: Transforming growth factor-betas and CD105 expression in calcification and bone formation in human atherosclerotic lesions. Zeitschrift für Kardiologie 90(Suppl): 23-26

Zhao, H.; Patra, A.; Tanaka, Y.; Li, L-Cheng.; Dahiya, R. 2002: Transforming growth factor-beta(s) and their receptors in aging rat prostate. Biochemical and Biophysical Research Communications 294(2): 464-469

Farkas, L.M.; Dünker, N.; Roussa, E.; Unsicker, K.; Krieglstein, K. 2003: Transforming growth factor-beta(s) are essential for the development of midbrain dopaminergic neurons in vitro and in vivo. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 23(12): 5178-5186

Jester, J.V.; Huang, J.; Barry-Lane, P.A.; Kao, W.W.; Petroll, W.M.; Cavanagh, H.D. 1999: Transforming growth factor(beta)-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly. IOVS Investigative Ophthalmology and Visual Science 40(9): 1959-1967

Slater, M.; Murphy, C.R. 2000: Transforming growth factors alpha and beta-1 are co-expressed in the uterine epithelium during early pregnancy. Cell and Tissue Research 300(2): 315-320

Platten, M.; Wick, W.; Wild-Bode, C.; Aulwurm, S.; Dichgans, J.; Weller, M. 2000: Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression. Biochemical and Biophysical Research Communications 268(2): 607-611

Pitman, A.R.; Boyd, L.A. 1999: Transforming local government wastewater departments - From adversary to industrial partner. Water Science and Technology 39(10-11): 39-45

Nevels, M.; Täuber, B.; Kremmer, E.; Spruss, T.; Wolf, H.; Dobner, T. 1999: Transforming potential of the adenovirus type 5 E4orf3 protein. Journal of Virology 73(2): 1591-1600

Lacronique, V.; Boureux, A.; Monni, R.; Dumon, S.; Mauchauffé, M.; Mayeux, P.; Gouilleux, F.; Berger, R.; Gisselbrecht, S.; Ghysdael, J.; Bernard, O.A. 2000: Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. Blood 95(6): 2076-2083

Djafer, M.; Luck, F.; Rose, J.P.; Cretenot, D. 2000: Transforming sludge into a recyclable and valuable carbon source by wet air oxidation. Water Science and Technology 41(8): 77-83

Nakano, H.; Murakami, H.; Shizuma, M.; Kiso, T.; de Araujo, T.L.; Kitahata, S. 2000: Transfructosylation of thiol group by beta-fructofuranosidases. Bioscience Biotechnology and Biochemistry 64(7): 1472-1476

Santala, M.; Järvelä, I.; Kauppila, A. 1999: Transfundal insertion of a Veress needle in laparoscopy of obese subjects: a practical alternative. Human Reproduction 14(9): 2277-2278

Atance, R.; Pereira, A.; Ramirez, B. 2001: Transfusing methylene blue-photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitate. Transfusion 41(12): 1548-1552

House, A.A.; Pham, B.; Pagé, D.E. 1998: Transfusion and recombinant human erythropoietin requirements differ between dialysis modalities. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 13(7): 1763-1769

Agence-Francaise-De-Securite-Sanitaire-Des-Produits-De-Sante-(Afssaps) author, Reprint-Author) 2003: Transfusion de globules rouges homologues: Produits, indications, alternatives. Annales Francaises d'Anesthesie et de Reanimation 22(1): 67-81

Fernandez, J.; Pressiani, V.; Solimano, J.; Koziner, B. 2001: Transfusion de granulocitos en enfermos neutropenicos por la vuelta. Medicina (Buenos Aires) 61(1): 93-104

Barton, J.C.; Bertoli, L.F. 2000: Transfusion iron overload in adults with acute leukemia: manifestations and therapy. American Journal of the Medical Sciences 319(2): 73-78

Choudhry, V.P. 2001: Transfusion medicine in the new millennium. Indian Journal of Pediatrics 68(1): 59

Ness, P.M. 2000: Transfusion medicine: an overview and update. Clinical Chemistry 46(8 Pt 2): 1270-1276

Goodnough, L.T.; Shander, A.; Brecher, M.E. 2003: Transfusion medicine: looking to the future. Lancet 361(9352): 161-169

Leal-Noval, S.R.; Rincón-Ferrari, M.D.; García-Curiel, A.; Herruzo-Avilés, A.; Camacho-Laraña, P.; Garnacho-Montero, J.; Amaya-Villar, R. 2001: Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 119(5): 1461-1468

Craven, C.M.; Ward, K. 1999: Transfusion of fetal cord blood cells: An improved method of hematopoietic stem cell transplantation?. Journal of Reproductive Immunology 42(1): 59-77

Matsunaga, M.; Nibu, K.; Yotsui, H.; Katori, K.; Sakuragi, T.; Higa, K. 2002: Transfusion of fresh frozen plasma for massive intraoperative bleeding before and after the new guidelines. Masui. Japanese Journal of Anesthesiology 51(7): 772-774

Wong, R.; Lau, F.Y.; Chui, C.H.; Tsang, K.S.; Chik, K.W.; Li, C.K.; Cheng, G. 2001: Transfusion of peripheral blood stem cells from donor homozygous for a shared HLA-haplotype: avoiding fatal transfusion-associated graft-versus-host disease while preserving anti-leukemic effect. Transplantation 71(3): 487-490

Pedrazzoli, P.; Noris, P.; Perotti, C.; Schiavo, R.; Ponchio, L.; Belletti, S.; Da Prada, G.A.; Balduini, C.L.; Salvaneschi, L.; Robustelli Della Cuna, G.; Siena, S. 2000: Transfusion of platelet concentrates cryopreserved with ThromboSol plus low-dose dimethylsulphoxide in patients with severe thrombocytopenia: A pilot study. British Journal of Haematology 108(3): 653-659

Raff, J.P.; Dobson, C.E.; Tsai, H.-M. 2002: Transfusion of polymerised human haemoglobin in a patient with severe sickle-cell anaemia. Lancet 360(9331): 464-465

Aurelio Vences Aviles, M.; Gil Villagomez, A.; Orozco Guzman, F.; Vega Santacruz, P. 1998: Transfusion practices in hospitalized patients. Revista Medica del Instituto Mexicano del Seguro Social 36(3): 211-215

Sakhnini, L.; Khuzaie, R. 2003: Transfusion regimen in beta thalassemia major using magnetic measurement techniques. World Journal of Microbiology and Biotechnology 19(5): 451-454

Herbert, P.C. 1998: Transfusion requirements in critical care (TRICC): A multicentre, randomized, controlled clinical study. British Journal of Anaesthesia 81(Suppl 1): 25-33

Chuansumrit, A.; Phimolthares, V.; Tardtong, P.; Tapaneya-Olarn, C.; Tapaneya-Olarn, W.; Kowsathit, P.; Chantarojsiri, T. 2000: Transfusion requirements in patients with dengue hemorrhagic fever. Southeast Asian Journal of Tropical Medicine and Public Health 31(1): 10-14

Whitaker, D.K. 2001: Transfusion strategy. European Journal of Anaesthesiology 18(8): 493-494

Capraro, L.; Nuutinen, L.; Myllylä, G. 2000: Transfusion thresholds in common elective surgical procedures in Finland. Vox Sanguinis 78(2): 96-100

Moolten, D.N. 2000: Transfusion transmitted cytomegalovirus. Pediatric Pathology and Molecular Medicine 19(2-3): 149-159

Ghosh, K.; Joshi, S.H.; Shetty, S.; Pawar, A.; Chipkar, S.; Pujari, V.; Madkaikar, M.; Pathare, A.V.; Jijina, F.; Mohanty, D. 2000: Transfusion transmitted diseases in haemophilics from western India. Indian Journal of Medical Research 112: 61-64

Shibuya, A.; Satomichi, A.; Takeuchi, A.; Saigenji, K.; Sakurai, K.; Kobayashi, N.; Yoshida, A. 2001: Transfusion transmitted virus infection in patients on maintenance haemodialysis and in hospital workers. Journal of Hospital Infection 47(4): 277-281

Stegeman, J.R.; Birkenheuer, A.J.; Kruger, J.M.; Breitschwerdt, E.B. 2003: Transfusion-associated Babesia gibsoni infection in a dog. Journal of the American Veterinary Medical Association 222(7): 959

Matsumoto, A.; Yeo, A.E.; Shih, J.W.; Tanaka, E.; Kiyosawa, K.; Alter, H.J. 1999: Transfusion-associated TT virus infection and its relationship to liver disease. Hepatology 30(1): 283-288

Gelly, K.J.; Kerr, R.; Rawlinson, S.; Norris, A.; Bowen, D.T. 2000: Transfusion-associated graft vs. host disease in a patient with high-grade B-cell lymphoma. Should cellular products for patients with non-Hodgkin's lymphoma be irradiated?. British Journal of Haematology 110(1): 228-229

Ozkan, H.; Oren, H.; Duman, N.; Ozkan, S.; Sarioğlu, S.; Anal, O.; Simşek, A.; Sağol, O.; Irken, G. 1999: Transfusion-associated graft-versus-host disease following exchange transfusion in a newborn. European Journal of Pediatrics 158(4): 343

Munro, L.R.; Culligan, D.J.; Grant, A.; Johnston, P.W.; Watson, H.G. 2002: Transfusion-associated graft-versus-host disease in a patient with Waldenstrom's macroglobulinaemia. Vox Sanguinis 83(3): 279-281

Tanei, R.; Ohta, Y.; Ishihara, S.; Katsuoka, K.; Yokono, H.; Motoori, T. 1999: Transfusion-associated graft-versus-host disease: an in situ hybridization analysis of the infiltrating donor-derived cells in the cutaneous lesion. Dermatology 199(1): 20-24

Saxena, R.; Thakur, V.; Sood, B.; Guptan, R.C.; Gururaja, S.; Sarin, S.K. 1999: Transfusion-associated hepatitis in a tertiary referral hospital in India. A prospective study. Vox Sanguinis 77(1): 6-10

Kühn 2000: Transfusion-associated infections with cytomegalovirus and other human herpesviruses. Infusionstherapie und Transfusionsmedizin 27(3): 138-143

Pinto, V.; Telenti, M.; Palomo, C.; Bernaldo De Quirós, J.F. 2000: Transfusion-associated sepsis caused by Candida parapsilosis. Vox Sanguinis 79(1): 57-58

Iolascon, A.; Martire, B.; Lee, M.J.; Wickramasinghe, S.N. 2000: Transfusion-dependent congenital dyserythropoietic anaemia with intraerythroblastic inclusions of a non-globin protein. European Journal of Haematology 65(2): 140-143

Wernet, D.; Schleicher, S.; Enkel, S.; Dehmer, T.; Northoff, H.; Flehmig, B. 1998: Transfusion-induced hepatitis C virus infection without detectable antivirus antibodies in the recipient. Infusionstherapie und Transfusionmedizin 25(6): 373-375

Lee, Y.H.; Lee, H.K.; Choi, K.H.; Hah, J.O.; Lim, S.Y. 2001: Transfusion-induced malaria in a child after open heart surgery in Korea. Journal of Korean Medical Science 16(6): 789-791

Medeiros, B.C.; Kogel, K.E.; Kane, M.A. 2003: Transfusion-related acute lung injury (TRALI) following platelet transfusion in a patient receiving high-dose interleukin-2 for treatment of metastatic renal cell carcinoma. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 29(1): 25-27

Santamaría, A.; Moya, F.; Martinez, C.; Martino, R.; Martinez-Pérez, J.; Muñiz-Díaz, E. 1998: Transfusion-related acute lung injury associated with an NA1-specific antigranulocyte antibody. Haematologica 83(10): 951-952

Lucas, G.; Rogers, S.; Evans, R.; Hambley, H.; Win, N. 2000: Transfusion-related acute lung injury associated with interdonor incompatibility for the neutrophil-specific antigen HNA-1a. Vox Sanguinis 79(2): 112-115

Flesch, B.K.; Neppert, Jürgen. 2002: Transfusion-related acute lung injury caused by human leucocyte antigen class II antibody. British Journal of Haematology 116(3): 673-676

Saigo, K.; Sugimoto, T.; Tone, K.; Ryo, R.; Kohsaki, M.; Tadokoro, K.; Kumagai, S. 1999: Transfusion-related acute lung injury in a patient with acute myelogenous leukaemia having anti-IgA2m(1) antibody. Journal of International Medical Research 27(2): 96-100

Lenahan, S.E.; Domen, R.E.; Silliman, C.C.; Kingsley, C.P.; Romano, P.J. 2001: Transfusion-related acute lung injury secondary to biologically active mediators. Archives of Pathology and Laboratory Medicine 125(4): 523-526

Bux, J. 2002: Transfusion-related acute lung injury: A neglected but life-threatening transfusion reaction. Infusion Therapy and Transfusion Medicine 29(5): 271-276

Kopko, P.M.; Marshall, C.S.; MacKenzie, M.R.; Holland, P.V.; Popovsky, M.A. 2002: Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 287(15): 1968-1971

Wallis, J.P.; Haynes, S.; Stark, G.; Green, F.A.; Lucas, G.F.; Chapman, C.E. 2002: Transfusion-related alloimmune neutropenia: an undescribed complication of blood transfusion. Lancet 360(9339): 1073-1074

Singbartl, G.; Kantak, S.; Munkel, H. 2001: Transfusion-related cost of adjunct aprotinin application in one-step infected hip revision arthroplasty: Cost-minimizing analysis. Infusion Therapy and Transfusion Medicine 28(2): 74-79

Tattevin, P.; Crémieux, A-Claude.; Descamps, D.; Carbon, C. 2002: Transfusion-related infectious mononucleosis. Scandinavian Journal of Infectious Diseases 34(10): 777-778

Tasaki, T.; Satoh, S.; Gotoh, K.; Fujii, K.; Sasaki, S.; Takadate, J.; Tachibana, M.; Ono, Y.; Ishida, Y. 2003: Transfusion-related problems following major ABO-incompatible bone marrow transplantation. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 28(2): 155-161

Nichols, W.G.; Price, T.H.; Gooley, T.; Corey, L.; Boeckh, M. 2003: Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products. Blood 101(10): 4195-4200

Moor, A.C.; Dubbelman, T.M.; VanSteveninck, J.; Brand, A. 1999: Transfusion-transmitted diseases: Risks, prevention and perspectives. European Journal of Haematology 62(1): 1-18

Soldan, K.; Barbara, J.A.J.; Dow, B.C. 2002: Transfusion-transmitted hepatitis B virus infection in the UK: A small and moving target. Vox Sanguinis 83(4): 305-308

He, C.; Nomura, F.; Yukimasa, N.; Itoga, S.; Yamada-Osaki, M.; Sumazaki, R.; Nakai, T. 1999: Transfusion-transmitted virus infection in China: Prevalence in blood donors and in patients with liver diseases. Journal of Gastroenterology and Hepatology 14(9): 899-903

Sparacia, G.; Iaia, A.; Banco, A.; D'Angelo, P.; Lagalla, R. 2000: Transfusional hemochromatosis: quantitative relation of MR imaging pituitary signal intensity reduction to hypogonadotropic hypogonadism. Radiology 215(3): 818-823

Barbosa Vosgerau, J.C. 1999: Transfusional toxoplasmosis, cardiovascular disorders, diabetes mellitus and thalidomide. Gazzetta Medica Italiana Archivio per le Scienze Mediche 158(4): 127-132

Ponce, C. 1999: Transfusional transmission of Chagas disease in Honduras and Central America. Medicina (Buenos Aires) 59(Suppl 2): 135-137

Sibrowski, W.; Cassens, U. 1998: Transfusions for critical care and high risk patients. Intensivmedizin und Notfallmedizin 35(Suppl 1): 102-108

Hardy, J.F.; Harel, F.; Bélisle, S. 2000: Transfusions in patients undergoing cardiac surgery with autologous blood. Canadian Journal of Anaesthesia 47(7): 705-711

Wajs, J. 2001: Transfuzje koncentratow granulocytarnych: Renesans niedocenianej metody leczenia?. Acta Haematologica Polonica 32(4): 385-392

Petzelbauer, I.; Reiter, A.; Splechtna, B.; Kosma, P.; Nidetzky, B. 2000: Transgalactosylation by thermostable beta-glycosidases from Pyrococcus furiosus and Sulfolobus solfataricus. Binding interactions of nucleophiles with the galactosylated enzyme intermediate make major contributions to the formation of new beta-glycosides during lactose conversion. European Journal of Biochemistry 267(16): 5055-5066

Ohara, S.; Takahashi, H.; Kato, M.; Nakamura, T.; Tsukada, M. 2000: Transganglionic gracile response following limb amputation in man. Acta Neuropathologica 100(5): 469-474

Sántha, P.; Jancsó, G. 2003: Transganglionic transport of choleragenoid by capsaicin-sensitive C-fibre afferents to the substantia gelatinosa of the spinal dorsal horn after peripheral nerve section. Neuroscience 116(3): 621-627

Wu-Scharf, D.; Jeong, B.; Zhang, C.; Cerutti, H. 2000: Transgene and transposon silencing in Chlamydomonas reinhardtii by a DEAH-box RNA helicase. Science 290(5494): 1159-1162

Brunham, R.C.; Zhang, D. 1999: Transgene as vaccine for chlamydia. American Heart Journal 138(5 Pt 2): S519-S522

Ajmani, P.S.; Wang, W.; Tang, F.; King, M.A.; Meyer, E.M.; Hughes, J.A. 2001: Transgene delivery with a cationic lipid in the presence of amyloid beta (betaAP) peptide. Neurochemical Research 26(3): 195-202

Haas, M.J.; Dragan, Y.P.; Hikita, H.; Shimel, R.; Takimoto, K.; Heath, S.; Vaughan, J.; Pitot, H.C. 1999: Transgene expression and repression in transgenic rats bearing the phosphoenolpyruvate carboxykinase-simian virus 40 T antigen or the phosphoenolpyruvate carboxykinase-transforming growth factor-alpha constructs. American Journal of Pathology 155(1): 183-192

Yamasoba, T.; Suzuki, M.; Kondo, K. 2002: Transgene expression in mature guinea pig cochlear cells in vitro. Neuroscience Letters 335(1): 13-16

Kanzaki, S.; Ogawa, K.; Camper, S.A.; Raphael, Y. 2002: Transgene expression in neonatal mouse inner ear explants mediated by first and advanced generation adenovirus vectors. Hearing Research 169(1-2): 112-120

Kohli, A.; Gahakwa, D.; Vain, P.; Laurie, D.A.; Christou, P. 1999: Transgene expression in rice engineered through particle bombardment: Molecular factors controlling stable expression and transgene silencing. Planta (Berlin) 208(1): 88-97

Han, J.J.; Mhatre, A.N.; Wareing, M.; Pettis, R.; Gao, W.Q.; Zufferey, R.N.; Trono, D.; Lalwani, A.K. 1999: Transgene expression in the guinea pig cochlea mediated by a lentivirus-derived gene transfer vector. Human Gene Therapy 10(11): 1867-1873

Zeidler, M.; Hartmann, E.; Hughes, J. 1999: Transgene expression in the moss Ceratodon purpureus. Journal of Plant Physiology 154(5-6): 641-650

Yoon, B.I.; Hirabayashi, Y.; Kaneko, T.; Kodama, Y.; Kanno, J.; Yodoi, J.; Kim, D.Y.; Inoue, T. 2001: Transgene expression of thioredoxin (TRX/ADF) protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced hematotoxicity. Archives of Environmental Contamination and Toxicology 41(2): 232-236

Meier, M., S.; Hilbeck, A. 2001: Transgene flow from crops to wild plants, consequences for associated insects and implications for hybrid fitness. Bulletin of the Geobotanical Institute ETH 67: 89-95

Pravtcheva, D.D.; Wise, T.L. 2003: Transgene instability in mice injected with an in vitro methylated Igf2 gene. Mutation Research 529(1-2): 35-50

Ray, P.S.; Martin, J.L.; Swanson, E.A.; Otani, H.; Dillmann, W.H.; Das, D.K. 2001: Transgene overexpression of alphaB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 15(2): 393-402

Kitamura, M. 1998: Transgene regulation by the tetracycline-controlled transactivation system. Experimental Nephrology 6(6): 576-580

Kumar, S.; Fladung, M. 2000: Transgene repeats in aspen: molecular characterisation suggests simultaneous integration of independent T-DNAs into receptive hotspots in the host genome. Molecular and General Genetics: Mgg 264(1-2): 20-28

Matzke, M.A.; Mette, M.F.; Matzke, A.J. 2000: Transgene silencing by the host genome defense: implications for the evolution of epigenetic control mechanisms in plants and vertebrates. Plant Molecular Biology 43(2-3): 401-415

Suemizu, H.; Muguruma, K.; Maruyama, C.; Tomisawa, M.; Kimura, M.; Hioki, K.; Shimozawa, N.; Ohnishi, Y.; Tamaoki, N.; Nomura, T. 2002: Transgene stability and features of rasH2 mice as an animal model for short-term carcinogenicity testing. Molecular Carcinogenesis 34(1): 1-9

Jansen, E.J.R.; Holling, T.M.; van Herp, Fçois.; Martens, G.J.M. 2002: Transgene-driven protein expression specific to the intermediate pituitary melanotrope cells of Xenopus laevis. FEBS Letters 516(1-3): 201-207

Hao, S.; Mata, M.; Goins, W.; Glorioso, J.C.; Fink, D.J. 2003: Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain. Pain 102(1-2): 135-142

Galvani, A.; Sperling, L. 2001: Transgene-mediated post-transcriptional gene silencing is inhibited by 3' non-coding sequences in Paramecium. Nucleic Acids Research 29(21): 4387-4394

Foran, C.M.; Peterson, B.N.; Benson, W.H. 2002: Transgenerational and developmental exposure of Japanese medaka (Oryzias latipes) to ethinylestradiol results in endocrine and reproductive differences in the response to ethinylestradiol as adults. Toxicological Sciences: An Official Journal of the Society of Toxicology 68(2): 389-402

Hoyes, K.P.; Lord, B.I.; McCann, C.; Hendry, J.H.; Morris, I.D. 2001: Transgenerational effects of preconception paternal contamination with (55)Fe. Radiation Research 156(5 Part 1): 488-494

Nirmala, K.; Oshima, Y.; Lee, R.; Imada, N.; Honjo, T.; Kobayashi, K. 1999: Transgenerational toxicity of tributyltin and its combined effects with polychlorinated biphenyls on reproductive processes in Japanese medaka (Oryzias latipes). Environmental Toxicology and Chemistry 18(4): 717-721

Antoniou, M.; Harland, L.; Mustoe, T.; Williams, S.; Holdstock, J.; Yague, E.; Mulcahy, T.; Griffiths, M.; Edwards, S.; Ioannou, P.A.; Mountain, A.; Crombie, R. 2003: Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. Genomics 82(3): 269-279

Wells, S.E.; Flavell, D.M.; Bisset, G.W.; Houston, P.A.; Christian, H.; Fairhall, K.M.; Robinson, I.C.A.F. 2003: Transgenesis and neuroendocrine physiology: A transgenic rat model expressing growth hormone in vasopressin neurones. Journal of Physiology 551(Pt 1): 323-336

Jenner, H.L. 2003: Transgenesis and yield: what are our targets?. Trends in Biotechnology 21(5): 190-192

Szopa, J. 2002: Transgenic 14-3-3 isoforms in plants: the metabolite profiling of repressed 14-3-3 protein synthesis in transgenic potato plants. Biochemical Society Transactions 30(4): 405-410

Andreassen, O.A.; Ferrante, R.J.; Klivenyi, P.; Klein, A.M.; Dedeoglu, A.; Albers, D.S.; Kowall, N.W.; Beal, M.F. 2001: Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid. Experimental Neurology 168(2): 356-363

Havouis, Séverine.; Dumas, Gérard.; Chambaud, I.; Ave, P.; Huerre, M.; Blanchard, A.; Dighiero, G.; Pourcel, C. 2002: Transgenic B lymphocytes expressing a human cold agglutinin escape tolerance following experimental infection of mice by Mycoplasma pulmonis. European Journal of Immunology 32(4): 1147-1156

Quiambao, A.B.; Tan, E.; Chang, S.; Komori, N.; Naash, M.I.; Peachey, N.S.; Matsumoto, H.; Ucker, D.S.; Al-Ubaidi, M.R. 2001: Transgenic Bcl-2 expressed in photoreceptor cells confers both death-sparing and death-inducing effects. Experimental Eye Research 73(5): 711-721

Reed, G., L.; Jensen, A., S.; Riebe, J.; Head, G.; Duan, J., J. 2001: Transgenic Bt potato and conventional insecticides for Colorado potato beetle management: Comparative efficacy and non-target impacts. Entomologia Experimentalis et Applicata 100(1): 89-100

Maier, L.S.; Zhang, T.; Chen, L.; DeSantiago, J.; Brown, J.H.; Bers, D.M. 2003: Transgenic CaMKIIdeltaC overexpression uniquely alters cardiac myocyte Ca2+ handling: reduced SR Ca2+ load and activated SR Ca2+ release. Circulation Research 92(8): 904-911

Saito, A.; Kamii, H.; Kato, I.; Takasawa, S.; Kondo, T.; Chan, P.H.; Okamoto, H.; Yoshimoto, T. 2001: Transgenic CuZn-superoxide dismutase inhibits NO synthase induction in experimental subarachnoid hemorrhage. Stroke 32(7): 1652-1657

Fossgreen, A.; Brückner, B.; Czech, C.; Masters, C.L.; Beyreuther, K.; Paro, R. 1998: Transgenic Drosophila expressing human amyloid precursor protein show gamma-secretase activity and a blistered-wing phenotype. Proceedings of the National Academy of Sciences of the United States of America 95(23): 13703-13708

Gal-On, A.; Wolf, D.; Pilowski, M.; Zelcer, A. 2000: Transgenic F1 hybrids harboring a defective viral replicase exhibit high resistance to CMV in the field. Acta Physiologiae Plantarum 22(3): 311-312

Ackermann, B.; Engel, B.C.; Buttlies, B.; Zibert, A.; Burdach, S. 2002: Transgenic IL-2 expression in Ewing tumor cell lines after transfection with Starburst dendrimers and cationic liposomes. Pediatric Hematology and Oncology 19(7): 509-520

Bradl, M.; Bauer, J.; Inomata, T.; Zielasek, J.; Nave, K.A.; Toyka, K.; Lassmann, H.; Wekerle, H. 1999: Transgenic Lewis rats overexpressing the proteolipid protein gene: Myelin degeneration and its effect on T cell-mediated experimental autoimmune encephalomyelitis. Acta Neuropathologica 97(6): 595-606

Yoshikawa, N.; Gotoh, S.; Umezawa, M.; Satoh, N.; Satoh, H.; Takahashi, T.; Ito, T.; Yoshida, K. 2000: Transgenic Nicotiana occidentalis Plants Expressing the 50-kDa Protein of Apple chlorotic leaf spot virus Display Increased Susceptibility to Homologous Virus, but Strong Resistance to Grapevine berry inner necrosis virus. Phytopathology 90(3): 311-316

Maglione, J.E.; Moghanaki, D.; Young, L.J.; Manner, C.K.; Ellies, L.G.; Joseph, S.O.; Nicholson, B.; Cardiff, R.D.; MacLeod, C.L. 2001: Transgenic Polyoma middle-T mice model premalignant mammary disease. Cancer Research 61(22): 8298-8305

Bendotti, C.; Tortarolo, M.; Suchak, S.K.; Calvaresi, N.; Carvelli, L.; Bastone, A.; Rizzi, M.; Rattray, M.; Mennini, T. 2001: Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. Journal of Neurochemistry 79(4): 737-746

Lemmer, Börn.; Witte, K.; Enzminger, H.; Schiffer, S.; Hauptfleisch, S. 2003: Transgenic TGR(mREN2)27 rats as a model for disturbed circadian organization at the level of the brain, the heart, and the kidneys. Chronobiology International 20(4): 711-738

Martin, D.C.; Sanchez-Sweatman, O.H.; Ho, A.T.; Inderdeo, D.S.; Tsao, M.S.; Khokha, R. 1999: Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis. Laboratory Investigation; A Journal of Technical Methods and Pathology 79(2): 225-234

Baumruk, F.; Flachs, P.; Horáková, M.; Floryk, D.; Kopecký, J. 1999: Transgenic UCP1 in white adipocytes modulates mitochondrial membrane potential. FEBS Letters 444(2-3): 206-210

Lupi, D.; Cooper, H.M.; Froehlich, A.; Standford, L.; Mccall, M.A.; Foster, R.G. 1999: Transgenic ablation of rod photoreceptors alters the circadian phenotype of mice. Neuroscience 89(2): 363-374

Mithofer, A.E.el, J.B.agwat, A.; Boller, T.N.uhaus-Url, G. 1999: Transgenic aequorin monitors cytosolic calcium transients in soybean cells challenged with beta-glucan or chitin elicitors. Planta 207(4): 566-574

Kedzierski, W.; Bok, D.; Travis, G.H. 1999: Transgenic analysis of Rds/peripherin N-glycosylation: Effect on dimerization, interaction with Rom1, and rescue of the rds null phenotype. Journal of Neurochemistry 72(1): 430-438

Kaufman, R.M.; Pham, C.T.; Ley, T.J. 1999: Transgenic analysis of a 100-kb human beta-globin cluster-containing DNA fragment propagated as a bacterial artificial chromosome. Blood 94(9): 3178-3184

Marquez, R.M.; Singer, M.A.; Takaesu, N.T.; Waldrip, W.R.; Kraytsberg, Y.; Newfeld, S.J. 2001: Transgenic analysis of the Smad family of TGF-beta signal transducers in Drosophila melanogaster suggests new roles and new interactions between family members. Genetics 157(4): 1639-1648

Parkes, T.L.; Kirby, K.; Phillips, J.P.; Hilliker, A.J. 1998: Transgenic analysis of the cSOD-null phenotypic syndrome in Drosophila. Genome 41(5): 642-651

Colnot, S.; Ovejero, C.; Romagnolo, B.; Porteu, A.; Lacourte, P.; Thomasset, M.; Perret, C. 2000: Transgenic analysis of the response of the rat calbindin-D 9k gene to vitamin D. Endocrinology 141(7): 2301-2308

Hoffman, P.L.; Yagi, T.; Tabakoff, B.; Phillips, T.J.; Kono, H.; Messing, R.O.; Choi, D.S. 2001: Transgenic and gene "knockout" models in alcohol research. Alcoholism Clinical and Experimental Research 25(5 Suppl Isbra): 60s-66s

Zuo, J. 2002: Transgenic and gene targeting studies of hair cell function in mouse inner ear. Journal of Neurobiology 53(2): 286-305

Anagnostopoulos, A.V.; Mobraaten, L.E.; Sharp, J.J.; Davisson, M.T. 2001: Transgenic and knockout databases: behavioral profiles of mouse mutants. Physiology and Behavior 73(5): 675-689

Ho, Y.-S. 2002: Transgenic and knockout models for studying the role of lung antioxidant enzymes in defense against hyperoxia. American Journal of Respiratory and Critical Care Medicine 166(12 Part 2): S51-S56

Murakami, K.; Fukamizu, A. 1999: Transgenic and knockout models in renin-angiotensin system. Immunopharmacology 44(1-2): 1-7

Asa, S.L. 2001: Transgenic and knockout mouse models clarify pituitary development, function and disease. Brain Pathology 11(3): 371-384

Olgin, J.E.; Verheule, S. 2002: Transgenic and knockout mouse models of atrial arrhythmias. Cardiovascular Research 54(2): 280-286

Hocher, B.; Paul, M. 2000: Transgenic animal models for the analysis of the renal endothelin system. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 15(7): 935-937

Eckert, R.L.; Crish, J.F.; Balasubramanian, S.; Rorke, E.A. 2000: Transgenic animal models of human papillomavirus-dependent disease (Review). International Journal of Oncology 16(5): 853-870

Williams, R.S.; Wagner, P.D. 2000: Transgenic animals in integrative biology: approaches and interpretations of outcome. Journal of Applied Physiology 88(3): 1119-1126

Seabrook, G.R.; Rosahl, T.W. 1999: Transgenic animals relevant to Alzheimer's disease. Neuropharmacology 38(1): 1-17

Bao, S.; Chen, L.; Qiao, X.; Thompson, R.F. 1999: Transgenic brain-derived neurotrophic factor modulates a developing cerebellar inhibitory synapse. Learning and Memory 6(3): 276-283

Bejar, R.; Yasuda, R.; Krugers, H.; Hood, K.; Mayford, M. 2002: Transgenic calmodulin-dependent protein kinase II activation: dose-dependent effects on synaptic plasticity, learning, and memory. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 22(13): 5719-5726

Wang, Y.; Fristensky, B. 2001: Transgenic canola lines expressing pea defense gene DRR206 have resistance to aggressive blackleg isolates and to Rhizoctonia solani. Molecular Breeding 8(3): 263-271

Sagoff, M. 2003: Transgenic chimeras. American Journal of Bioethics: Ajob 3(3): 30-31

Wang, X.J.; Greenhalgh, D.A.; Roop, D.R. 2000: Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation. Molecular Carcinogenesis 27(3): 200-209

Kowalski, T.J.; Liu, S.M.; Leibel, R.L.; Chua, S.C. 2001: Transgenic complementation of leptin-receptor deficiency. I. Rescue of the obesity/diabetes phenotype of LEPR-null mice expressing a LEPR-B transgene. Diabetes 50(2): 425-435

Baldwin, F.L. 2000: Transgenic crops: A view from the US Extension Service. Pest Management Science 56(7): 584-585

Pessel, F.D.; Lecomte, J.; Gouyon, P.H.nri 1998: Transgenic crops: Assessment to risk management. Cahiers Agricultures 7(6): 541-546

Warwick, S.I.; Beckie, H.J.; Small, E. 1999: Transgenic crops: New weed problems for Canada?. Phytoprotection 80(2): 71-84

Xia, Y.-P.; Li, B.; Hylton, D.; Detmar, M.; Yancopoulos, G.D.; Rudge, J.S. 2003: Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 102(1): 161-168

Zhang, S.; Song, W.-Yuan; Chen, L.; Ruan, D.; Taylor, N.; Ronald, P.; Beachy, R.; Fauquet, C. 1998: Transgenic elite Indica rice varieties, resistant to Xanthomonas oryzae pv. oryzae. Molecular Breeding 4(6): 551-558

Yang, Y.; McKerlie, C.; Borenstein, S.H.; Lu, Z.; Schito, M.; Chamberlain, J.W.; Buchwald, M. 2002: Transgenic expression in mouse lung reveals distinct biological roles for the adenovirus type 5 E1A 243- and 289-amino-acid proteins. Journal of Virology 76(17): 8910-8919

Holtmaat, A.J.G.D.; Huizinga, C.T.; Margolis, F.L.; Gispen, W.H.; Verhaagen, J. 1999: Transgenic expression of B-50/GAP-43 in mature olfactory neurons triggers downregulation of native B-50/GAP-43 expression in immature olfactory neurons. Molecular Brain Research 74(1-2): 197-207

Dotti, G.; Savoldo, B.; Yotnda, P.; Rill, D.; Brenner, M.K. 2002: Transgenic expression of CD40 ligand produces an in vivo antitumor immune response against both CD40(+) and CD40(-) plasmacytoma cells. Blood 100(1): 200-207

Yamaoka, T.; Yoshino, K.; Yamada, T.; Yano, M.; Matsui, T.; Yamaguchi, T.; Moritani, M.; Hata, J-ichi.; Noji, S.; Itakura, M. 2002: Transgenic expression of FGF8 and FGF10 induces transdifferentiation of pancreatic islet cells into hepatocytes and exocrine cells. Biochemical and Biophysical Research Communications 292(1): 138-143

Chaum, E.; Yang, H. 2002: Transgenic expression of IGF-1 modifies the proliferative potential of human retinal pigment epithelial cells. IOVS Investigative Ophthalmology and Visual Science 43(12): 3758-3764

French, M.B.; Koch, U.; Shaye, R.E.; McGill, M.A.; Dho, S.E.; Guidos, C.J.; McGlade, C.J. 2002: Transgenic expression of numb inhibits notch signaling in immature thymocytes but does not alter T cell fate specification. Journal of Immunology 168(7): 3173-3180

Norment, A.M.; Bogatzki, L.Y.; Klinger, M.; Ojala, E.W.; Bevan, M.J.; Kay, R.J. 2003: Transgenic expression of RasGRP1 induces the maturation of double-negative thymocytes and enhances the production of CD8 single-positive thymocytes. Journal of Immunology 170(3): 1141-1149

DeLeo, J.A.; Rutkowski, M.D.; Stalder, A.K.; Campbell, I.L. 2000: Transgenic expression of TNF by astrocytes increases mechanical allodynia in a mouse neuropathy model. Neuroreport 11(3): 599-602

Lin, X.; Njenga, M.K.; Johnson, A.J.; Pavelko, K.D.; David, C.S.; Pease, L.R.; Rodriguez, M. 2002: Transgenic expression of Theiler's murine encephalomyelitis virus genes in H-2(b) mice inhibits resistance to virus-induced demyelination. Journal of Virology 76(15): 7799-7811

Perkins, B.D.; Kainz, P.M.; O'Malley, D.M.; Dowling, J.E. 2002: Transgenic expression of a GFP-rhodopsin COOH-terminal fusion protein in zebrafish rod photoreceptors. Visual Neuroscience 19(3): 257-264

Kudo, T.; Kure, S.; Ikeda, K.; Xia, A.-P.; Katori, Y.; Suzuki, M.; Kojima, K.; Ichinohe, A.; Suzuki, Y.; Aoki, Y.; Kobayashi, T.; Matsubara, Y. 2003: Transgenic expression of a dominant-negative connexin26 causes degeneration of the organ of Corti and non-syndromic deafness. Human Molecular Genetics 12(9): 995-1004

Findlay, G.S.; Wick, M.J.; Mascia, M.P.; Wallace, D.; Miller, G.W.; Harris, R.A.; Blednov, Y.A. 2002: Transgenic expression of a mutant glycine receptor decreases alcohol sensitivity of mice. Journal of Pharmacology and Experimental Therapeutics 300(2): 526-534

Bao, L.; Haas, M.; Boackle, S.A.; Kraus, D.M.; Cunningham, P.N.; Park, P.; Alexander, J.J.; Anderson, R.K.; Culhane, K.; Holers, V.Michael.; Quigg, R.J. 2002: Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice. Journal of Immunology 168(7): 3601-3607

Xu, H.; Wawrousek, E.F.; Redmond, T.M.; Nickerson, J.M.; Wiggert, B.; Chan, C.C.; Caspi, R.R. 2000: Transgenic expression of an immunologically privileged retinal antigen extraocularly enhances self tolerance and abrogates susceptibility to autoimmune uveitis. European Journal of Immunology 30(1): 272-278

Miyake, J.H.; Duong-Polk, X.T.; Taylor, J.M.; Du, E.Z.; Castellani, L.W.; Lusis, A.J.; Davis, R.A. 2002: Transgenic expression of cholesterol-7-alpha-hydroxylase prevents atherosclerosis in C57BL/6J mice. Arteriosclerosis Thrombosis and Vascular Biology 22(1): 121-126

Miliani de Marval, P.L.; Gimenez-Conti, I.B.; LaCava, M.; Martinez, L.A.; Conti, C.J.; Rodriguez-Puebla, M.L. 2001: Transgenic expression of cyclin-dependent kinase 4 results in epidermal hyperplasia, hypertrophy, and severe dermal fibrosis. American Journal of Pathology 159(1): 369-379

Krakowski, M.L.; Kritzik, M.R.; Jones, E.M.; Krahl, T.; Lee, J.; Arnush, M.; Gu, D.; Mroczkowski, B.; Sarvetnick, N. 1999: Transgenic expression of epidermal growth factor and keratinocyte growth factor in beta-cells results in substantial morphological changes. Journal of Endocrinology 162(2): 167-175

Wang, J.; Snider, D.P.; Hewlett, B.R.; Lukacs, N.W.; Gauldie, J.; Liang, H.; Xing, Z. 2000: Transgenic expression of granulocyte-macrophage colony-stimulating factor induces the differentiation and activation of a novel dendritic cell population in the lung. Blood 95(7): 2337-2345

Young, W.S.; Iacangelo, A.; Luo, X.Z.; King, C.; Duncan, K.; Ginns, E.I. 1999: Transgenic expression of green fluorescent protein in mouse oxytocin neurones. Journal of Neuroendocrinology 11(12): 935-939

Qin, X.; Zhou, H.; Liu, L.; Gerson, S.L. 1999: Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis. Carcinogenesis 20(9): 1667-1673

Carr, D.J.; Campbell, I.L. 1999: Transgenic expression of interleukin-6 in the central nervous system confers protection against acute herpes simplex virus type-1 infection. Journal of Neurovirology 5(5): 449-457

Everett, A.D.; Kamibayashi, C.; Brautigan, D.L. 2002: Transgenic expression of protein phosphatase 2A regulatory subunit B56gamma disrupts distal lung differentiation. American Journal of Physiology. Lung Cellular and Molecular Physiology 282(6): L1266-L1271

Ito, K.; Yan, X.; Feng, X.; Manning, W.J.; Dillmann, W.H.; Lorell, B.H. 2001: Transgenic expression of sarcoplasmic reticulum Ca(2+) atpase modifies the transition from hypertrophy to early heart failure. Circulation Research 89(5): 422-429

Grossman, D.; Kim, P.J.; Blanc-Brude, O.P.; Brash, D.E.; Tognin, S.; Marchisio, P.C.; Altieri, D.C. 2001: Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. Journal of Clinical Investigation 108(7): 991-999

Morimoto, K.-i.; Shimizu, T.; Furukawa, K.; Morio, H.; Kurosawa, H.; Shirasawa, T. 2002: Transgenic expression of the EXT2 gene in developing chondrocytes enhances the synthesis of heparan sulfate and bone formation in mice. Biochemical and Biophysical Research Communications 292(4): 999-1009

Lee, S.-H.; Zafer, A.; de Repentigny, Y.; Kothary, R.; Tremblay, M.L.; Gros, P.; Duplay, P.; Webb, J.R.; Vidal, S.M. 2003: Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. Journal of Experimental Medicine 197(4): 515-526

Yang, T.Y.; Chen, S.C.; Leach, M.W.; Manfra, D.; Homey, B.; Wiekowski, M.; Sullivan, L.; Jenh, C.H.; Narula, S.K.; Chensue, S.W.; Lira, S.A. 2000: Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. Journal of Experimental Medicine 191(3): 445-454

Wan, Y.Y.; Leon, R.P.; Marks, R.; Cham, C.M.; Schaack, J.; Gajewski, T.F.; DeGregori, J. 2000: Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells. Proceedings of the National Academy of Sciences of the United States of America 97(25): 13784-13789

Lagresle, C.; Gardie, B.; Eyquem, S.ép.; Fasseu, M.; Vieville, J.-C.; Pla, M.; Sigaux, F.ço.; Bories, J.-C. 2002: Transgenic expression of the p16(INK4a) cyclin-dependent kinase inhibitor leads to enhanced apoptosis and differentiation arrest of CD4-CD8- immature thymocytes. Journal of Immunology 168(5): 2325-2331

Shimizu, T.; Ikegami, T.; Ogawara, M.; Suzuki, Y.-i.; Takahashi, M.; Morio, H.; Shirasawa, T. 2002: Transgenic expression of the protein-L-isoaspartyl methyltransferase (PIMT) gene in the brain rescues mice from the fatal epilepsy of PIMT deficiency. Journal of Neuroscience Research 69(3): 341-352

Brion, J.P.; Tremp, G.; Octave, J.N. 1999: Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. American Journal of Pathology 154(1): 255-270

Rosochacki, S., J.; Zwierzchowski, L. 2000: Transgenic fish: Advances, problems and perspectives: A review. Prace i Materialy Zootechniczne 56: 75-95

Van Emden, H.F. 1999: Transgenic host plant resistance to insects: Some reservations. Annals of the Entomological Society of America 92(6): 788-797

Anoop, N.; Gupta, A.K. 2003: Transgenic indica rice cv IR-50 over-expressing Vigna aconitifolia DELTA1-pyrroline -5- carboxylate synthetase cDNA shows tolerance to high salt. Journal of Plant Biochemistry and Biotechnology 12(2): 109-116

Cua, D.J.; Groux, H.; Hinton, D.R.; Stohlman, S.A.; Coffman, R.L. 1999: Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. Journal of Experimental Medicine 189(6): 1005-1010

Link, C.D. 2001: Transgenic invertebrate models of age-associated neurodegenerative diseases. Mechanisms of Ageing and Development 122(14): 1639-1649

Chang, J.C.; Lu, R.; Lin, C.; Xu, S.M.; Kan, Y.W.; Porcu, S.; Carlson, E.; Kitamura, M.; Yang, S.; Flebbe-Rehwaldt, L.; Gaensler, K.M. 1998: Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: a mouse model of sickle cell anemia. Proceedings of the National Academy of Sciences of the United States of America 95(25): 14886-14890

Harris, S. 2001: Transgenic knockouts as part of high-throughput, evidence-based target selection and validation strategies. Drug Discovery Today 6(12): 628-636

Niemann, H.; Kues, W.A. 2000: Transgenic livestock: premises and promises. Animal Reproduction Science 60-61: 277-293

Yang-Kai; Cheng-Han-Hua; Guo-Yi-Qing; Zhou-Rong-Jia 2001: Transgenic loach produced by using sperm cells mediated by high molecules. Acta Genetica Sinica 28(12): 1137-1141

Tang, W.; Tian, Y. 2003: Transgenic loblolly pine (Pinus taeda L.) plants expressing a modified delta-endotoxin gene of Bacillus thuringiensis with enhanced resistance to Dendrolimus punctatus Walker and Crypyothelea formosicola Staud. Journal of Experimental Botany 54(383): 835-844

Wang-Jing-Xue; Sun-Yi; Cui-Gui-Mei; Hu-Jing-Jing 2001: Transgenic maize plants obtained by pollen-mediated transformation. Acta Botanica Sinica 43(3): 275-279

O'-Connor-Sanchez, A.C.brera-Ponce, J.; Valdez-Melara, M.T.llez-Rodriguez, P.P.ns-Hernandez, J.; Herrera-Estrella, L. 2002: Transgenic maize plants of tropical and subtropical genotypes obtained from calluses containing organogenic and embryogenic-like structures derived from shoot tips. Plant cell reports 21(4): 302-312

Tower, J. 2000: Transgenic methods for increasing Drosophila life span. Mechanisms of Ageing and Development 118(1-2): 1-14

Guo-Ren; Chen-Shu-Fan; Luo-Qi-Sheng; Wang-Qing-Ling; Yi-Hong-Kun; Zhan-Qiong-Fen 1999: Transgenic mice as a model for neurovirulence test of live poliomyelitis vaccines. Zoological Research 20(4): 241-246

Dragunsky, E.; Nomura, T.; Karpinski, K.; Furesz, J.; Wood, D.J.; Pervikov, Y.; Abe, S.; Kurata, T.; Vanloocke, O.; Karganova, G.; Taffs, R.; Heath, A.; Ivshina, A.; Levenbook, I. 2003: Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study. Bulletin of the World Health Organization 81(4): 251-260

Seznec, H.; Lia-Baldini, A.S.; Duros, C.; Fouquet, C.; Lacroix, C.; Hofmann-Radvanyi, H.; Junien, C.; Gourdon, G. 2000: Transgenic mice carrying large human genomic sequences with expanded CTG repeat mimic closely the DM CTG repeat intergenerational and somatic instability. Human Molecular Genetics 9(8): 1185-1194

Mimatsu, K.; Zhou, Y.H.; Kusumi, Y.; Ikeda, T.; Mitsumata, M.; Esumi, M. 2000: Transgenic mice carrying the entire coding region of the hepatitis C virus. Nichidai Igaku Zasshi 59(11): 532-537

Wang, H.; Hicks, J.; Khanbolooki, P.; Kim, S.-J.; Yan, C.; Wang, Y.; Boyd, D. 2003: Transgenic mice demonstrate novel promoter regions for tissue-specific expression of the urokinase receptor gene. American Journal of Pathology 163(2): 453-464

Gelman, D.M.; Noaín, D.; Avale, M.E.; Otero, V.ón.; Low, M.J.; Rubinstein, M. 2003: Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons. Genesis 36(4): 196-202

Welsh, M.; Christmansson, L.; Karlsson, T.; Sandler, S.; Welsh, N. 1999: Transgenic mice expressing Shb adaptor protein under the control of rat insulin promoter exhibit altered viability of pancreatic islet cells. Molecular Medicine 5(3): 169-180

Klevenyi, P.; Andreassen, O.; Ferrante, R.J.; Schleicher, J.R.; Friedlander, R.M.; Beal, M.F. 1999: Transgenic mice expressing a dominant negative mutant interleukin-1beta converting enzyme show resistance to MPTP neurotoxicity. Neuroreport 10(3): 635-638

Gorska, A.E.; Jensen, R.A.; Shyr, Y.; Aakre, M.E.; Bhowmick, N.A.; Moses, H.L. 2003: Transgenic mice expressing a dominant-negative mutant type Ii transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation. American Journal of Pathology 163(4): 1539-1549

Ohmori, S.; Hayashi, Y.; Yamamoto, M.; Kambe, F.; Ogawa, M.; Kamijo, T.; Seo, H. 2002: Transgenic mice expressing a mutant human GH gene causing type II IGHD. Environmental Medicine 46(1-2): 36-39

Metzger, F.; Repunte-Canonigo, V.; Matsushita, S.; Akemann, W.; Diez-Garcia, J.; Ho, C.Shun.; Iwasato, T.; Grandes, P.; Itohara, S.; Joho, R.H.; Knöpfel, T. 2002: Transgenic mice expressing a pH and Cl- sensing yellow-fluorescent protein under the control of a potassium channel promoter. European Journal of Neuroscience 15(1): 40-50

Arlotta, P.; Tai, A.K.; Manfioletti, G.; Clifford, C.; Jay, G.; Ono, S.J. 2000: Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas. Journal of Biological Chemistry 275(19): 14394-14400

Ogueta, S.; Olazabal, I.; Santos, I.; Delgado-Baeza, E.; García-Ruiz, J.P. 2000: Transgenic mice expressing bovine GH develop arthritic disorder and self-antibodies. Journal of Endocrinology 165(2): 321-328

Kokubo, Y.; Matson, G.B.; Derugin, N.; Hill, T.; Mancuso, A.; Chan, P.H.; Weinstein, P.R. 2002: Transgenic mice expressing human copper-zinc superoxide dismutase exhibit attenuated apparent diffusion coefficient reduction during reperfusion following focal cerebral ischemia. Brain Research 947(1): 1-8

Tomlinson, E.; Fu, L.; John, L.; Hultgren, B.; Huang, X.; Renz, M.; Stephan, J.P.; Tsai, S.P.; Powell-Braxton, L.; French, D.; Stewart, T.A. 2002: Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 143(5): 1741-1747

Feng, C.G.; Kullberg, M.C.; Jankovic, D.; Cheever, A.W.; Caspar, P.; Coffman, R.L.; Sher, A. 2002: Transgenic mice expressing human interleukin-10 in the antigen-presenting cell compartment show increased susceptibility to infection with Mycobacterium avium associated with decreased macrophage effector function and apoptosis. Infection and Immunity 70(12): 6672-6679

Hensley, L.L.; Ranganathan, G.; Wagner, E.M.; Wells, B.D.; Daniel, J.C.; Vu, D.; Semenkovich, C.F.; Zechner, R.; Kern, P.A. 2003: Transgenic mice expressing lipoprotein lipase in adipose tissue. Absence of the proximal 3'-untranslated region causes translational upregulation. Journal of Biological Chemistry 278(35): 32702-32709

Ruchoux, M.M.; Domenga, V.ér.; Brulin, P.; Maciazek, J.; Limol, S.; Tournier-Lasserve, E.; Joutel, A. 2003: Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. American Journal of Pathology 162(1): 329-342

Sunada, Y.; Ohi, H.; Hase, A.; Ohi, H.; Hosono, T.; Arata, S.; Higuchi, S.; Matsumura, K.; Shimizu, T. 2001: Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity. Human Molecular Genetics 10(3): 173-178

Reddy, P.H.; Charles, V.; Williams, M.; Miller, G.; Whetsell, W.O.; Tagle, D.A. 1999: Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 354(1386): 1035-1045

Hsieh, S.; Chen, N.; Tarbell, K.; Liao, N.; Lai, Y.; Lee, K.; Lee, K.; Wu, S.; Sytwu, H.; Han, S.; McDevitt, H. 2000: Transgenic mice expressing surface markers for IFN-gamma and IL-4 producing cells. Molecular Immunology 37(6): 281-293

Lalonde, R.; Qian, S.; Strazielle, C. 2003: Transgenic mice expressing the PS1-A246E mutation: Effects on spatial learning, exploration, anxiety, and motor coordination. Behavioural Brain Research 138(1): 71-79, 6th January

Lalonde, R.; Lewis, T.L.; Strazielle, C.; Kim, H.; Fukuchi, K. 2003: Transgenic mice expressing the betaAPP695SWE mutation: effects on exploratory activity, anxiety, and motor coordination. Brain Research 977(1): 38-45

Cha, J-Heon.; Chang, M.Young.; Richardson, J.A.; Eidels, L. 2003: Transgenic mice expressing the diphtheria toxin receptor are sensitive to the toxin. Molecular Microbiology 49(1): 235-240

Kadish, I.; Pradier, L.; Van Groen, T. 2002: Transgenic mice expressing the human presenilin 1 gene demonstrate enhanced hippocampal reorganization following entorhinal cortex lesions. Brain Research Bulletin 57(5): 587-594

Sato, T.; Oyake, M.; Nakamura, K.; Nakao, K.; Fukusima, Y.; Onodera, O.; Igarashi, S.; Takano, H.; Kikugawa, K.; Ishida, Y.; Shimohata, T.; Koide, R.; Ikeuchi, T.; Tanaka, H.; Futamura, N.; Matsumura, R.; Takayanagi, T.; Tanaka, F.; Sobue, G.; Komure, O.; Takahashi, M.; Sano, A.; Ichikawa, Y.; Goto, J.; Kanazawa, I. 1999: Transgenic mice harboring a full-length human mutant DRPLA gene exhibit age-dependent intergenerational and somatic instabilities of CAG repeats comparable with those in DRPLA patients. Human Molecular Genetics 8(1): 99-106

Hämäläinen, T.; Kero, J.; Poutanen, M.; Huhtaniemi, I. 2002: Transgenic mice harboring murine luteinizing hormone receptor promoter/beta-galactosidase fusion genes: different structural and hormonal requirements of expression in the testis, ovary, and adrenal gland. Endocrinology 143(10): 4096-4103

McLeod, A.L.; Ritchie, J.; Cuello, A.C.; Julien, J.P.; Ribeiro-Da-Silva, A.; Henry, J.L. 1999: Transgenic mice over-expressing substance P exhibit allodynia and hyperalgesia which are reversed by substance P and N-methyl-D-aspartate receptor antagonists. Neuroscience 89(3): 891-899

Jin, L.W.; Hearn, M.G.; Ogburn, C.E.; Dang, N.; Nochlin, D.; Ladiges, W.C.; Martin, G.M. 1998: Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis. American Journal of Pathology 153(6): 1679-1686

Trapp, T.; Korhonen, L.; Besselmann, M.; Martinez, R.; Mercer, E.A.; Lindholm, D. 2003: Transgenic mice overexpressing XIAP in neurons show better outcome after transient cerebral ischemia. Molecular and Cellular Neurosciences 23(2): 302-313

Song, Z.; Fu, D.T.W.; Chan, Y-Shing.; Leung, S.; Chung, S.S.M.; Chung, S.K. 2003: Transgenic mice overexpressing aldose reductase in Schwann cells show more severe nerve conduction velocity deficit and oxidative stress under hyperglycemic stress. Molecular and Cellular Neurosciences 23(4): 638-647

Devedjian, J.C.; Pujol, A.; Cayla, C.; George, M.; Casellas, A.; Paris, H.; Bosch, F. 2000: Transgenic mice overexpressing alpha2A-adrenoceptors in pancreatic beta-cells show altered regulation of glucose homeostasis. Diabetologia 43(7): 899-906

Vogel, J.; Kiessling, I.; Heinicke, K.; Stallmach, T.; Ossent, P.; Vogel, O.; Aulmann, M.; Frietsch, T.; Schmid-Schönbein, H.; Kuschinsky, W.; Gassmann, M. 2003: Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity. Blood 102(6): 2278-2284

Selzner, M.; Rüdiger, H.A.; Selzner, N.; Thomas, D.W.; Sindram, D.; Clavien, P.Alain. 2002: Transgenic mice overexpressing human Bcl-2 are resistant to hepatic ischemia and reperfusion. Journal of Hepatology 36(2): 218-225

Demolombe, S.; Lande, G.; Charpentier, F.; van Roon, M.A.; van den Hoff, M.J.; Toumaniantz, G.; Baro, I.; Guihard, G.; Le Berre, N.; Corbier, A.; de Bakker, J.; Opthof, T.; Wilde, A.; Moorman, A.F.; Escande, D. 2001: Transgenic mice overexpressing human KvLQT1 dominant-negative isoform. Part I: Phenotypic characterisation. Cardiovascular Research 50(2): 314-327

Lande, G.; Demolombe, S.; Bammert, A.; Moorman, A.; Charpentier, F.; Escande, D. 2001: Transgenic mice overexpressing human KvLQT1 dominant-negative isoform. Part II: Pharmacological profile. Cardiovascular Research 50(2): 328-334

Devedjian, J.C.; George, M.; Casellas, A.; Pujol, A.; Visa, J.; Pelegrín, M.; Gros, L.; Bosch, F. 2000: Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes. Journal of Clinical Investigation 105(6): 731-740

Arad, M.; Moskowitz, I.P.; Patel, V.V.; Ahmad, F.; Perez-Atayde, A.R.; Sawyer, D.B.; Walter, M.; Li, G.H.; Burgon, P.G.; Maguire, C.T.; Stapleton, D.; Schmitt, J.P.; Guo, X.X.; Pizard, A.; Kupershmidt, S.; Roden, D.M.; Berul, C.I.; Seidman, C.E.; Seidman, J.G. 2003: Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation 107(22): 2850-2856

Reddig, P.J.; Dreckschmidt, N.E.; Ahrens, H.; Simsiman, R.; Tseng, C.P.; Zou, J.; Oberley, T.D.; Verma, A.K. 1999: Transgenic mice overexpressing protein kinase Cdelta in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Research 59(22): 5710-5718

Angel, N.Z.; Walsh, N.; Forwood, M.R.; Ostrowski, M.C.; Cassady, A.I.; Hume, D.A. 2000: Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 15(1): 103-110

Debeljuk, L.; Wright, J.C.; Phelps, C.; Bartke, A. 1999: Transgenic mice overexpressing the growth-hormone-releasing hormone gene have high concentrations of tachykinins in the anterior pituitary gland. Neuroendocrinology 70(2): 107-116

Saarelainen, T.; Lukkarinen, J.A.; Koponen, S.; Gröhn, O.H.; Jolkkonen, J.; Koponen, E.; Haapasalo, A.; Alhonen, L.; Wong, G.; Koistinaho, J.; Kauppinen, R.A.; Castrén, E. 2000: Transgenic mice overexpressing truncated trkB neurotrophin receptors in neurons show increased susceptibility to cortical injury after focal cerebral ischemia. Molecular and Cellular Neurosciences 16(2): 87-96

Jagger, C.; Chambers, T.; Pondel, M. 2000: Transgenic mice reveal novel sites of calcitonin receptor gene expression during development. Biochemical and Biophysical Research Communications 274(1): 124-129

Ma, Y.H.; Fei, J.; Hu, J.H.; Zhou, X.G.; Xia, G.H.; Guo, L.H. 2001: Transgenic mice ubiquitously expressing human Fas ligand develop a slight form of graft-versus-host-like disease. Acta Pharmacologica Sinica 22(4): 311-319

Stoddart, J.H.; Ladd, D.; Bronson, R.T.; Harmon, M.; Jaworski, J.; Pritzker, C.; Lausen, N.; Smith, B.D. 2000: Transgenic mice with a mutated collagen promoter display normal response during bleomycin-induced fibrosis and possess neurological abnormalities. Journal of Cellular Biochemistry 77(1): 135-148

Adachi, H.; Kume, A.; Li, M.; Nakagomi, Y.; Niwa, H.; Do, J.; Sang, C.; Kobayashi, Y.; Doyu, M.; Sobue, G. 2001: Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death. Human Molecular Genetics 10(10): 1039-1048

Okamoto, Y.; Chaves, A.; Chen, J.; Kelley, R.; Jones, K.; Weed, H.G.; Gardner, K.L.; Gangi, L.; Yamaguchi, M.; Klomkleaw, W.; Nakayama, T.; Hamlin, R.L.; Carnes, C.; Altschuld, R.; Bauer, J.; Hai, T. 2001: Transgenic mice with cardiac-specific expression of activating transcription factor 3, a stress-inducible gene, have conduction abnormalities and contractile dysfunction. American Journal of Pathology 159(2): 639-650

De Boer, J.; Williams, A.; Skavdis, G.; Harker, N.; Coles, M.; Tolaini, M.; Norton, T.; Williams, K.; Roderick, K.; Potocnik, A.J.; Kioussis, D. 2003: Transgenic mice with hematopoietic and lymphoid specific expression of Cre. European Journal of Immunology 33(2): 314-325

Tang, J.; Neidigh, J.L.; Cooksey, R.C.; McClain, D.A. 2000: Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance. Diabetes 49(9): 1492-1499

Rondi-Reig, L.; Lemaigre-Dubreuil, Y.; Montécot, C.; Müller, D.; Martinou, J.C.; Caston, J.; Mariani, J. 2001: Transgenic mice with neuronal overexpression of bcl-2 gene present navigation disabilities in a water task. Neuroscience 104(1): 207-215

Wan, L.; Chung, S.K.; Yang, Y.; Chung, S.S.; Cao, D.; Ma, M.; Wu, M.; Wan, Z.; Chen, X. 2001: Transgenic mice with overexpression of human scavenger receptor A on endothelial cells. Chinese Medical Journal 114(10): 1078-1083

Syed, N.A.; Windle, J.J.; Darjatmoko, S.R.; Lokken, J.M.; Steeves, R.A.; Chappell, R.; Wallow, I.H.; Koop, B.A.; Mangold, G.; Howes, K.A.; Albert, D.M. 1998: Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment. IOVS Investigative Ophthalmology and Visual Science 39(13): 2800-2805

Moechars, D.; De-Strooper, B.; Dewachter, I.; Van-Leuven, F. 1998: Transgenic mice, derived neurons and organotypic cultures as model systems to study Alzheimer's disease. Mededelingen van de Faculteit Landbouwwetenschappen - Rijksuniversiteit Gent 63(4A): 1099-1105

Babinet, C. 2000: Transgenic mice: an irreplaceable tool for the study of mammalian development and biology. Journal of the American Society of Nephrology: Jasn 11(Suppl): S88-S94

Qin, W.; Rudolph, A.E.; Bond, B.R.; Rocha, R.; Blomme, E.A.G.; Goellner, J.J.; Funder, J.W.; McMahon, E.G. 2003: Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure. Circulation Research 93(1): 69-76

James, J.; Zhang, Y.; Osinska, H.; Sanbe, A.; Klevitsky, R.; Hewett, T.E.; Robbins, J. 2000: Transgenic modeling of a cardiac troponin i mutation linked to familial hypertrophic cardiomyopathy. Circulation Research 87(9): 805-811

Sinn, P.L.; Sigmund, C.D. 2000: Transgenic models as tools for studying the regulation of human renin expression. Regulatory Peptides 86(1-3): 77-82

Zollmann, F.S.; Paul, M. 2000: Transgenic models for the study of endothelin function in the cardiovascular system. Journal of Cardiovascular Pharmacology 35(4 Suppl 2): S13-S16

Ho, Y.S.; Vincent, R.; Dey, M.S.; Slot, J.W.; Crapo, J.D. 1998: Transgenic models for the study of lung antioxidant defense: enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. American Journal of Respiratory Cell and Molecular Biology 18(4): 538-547

Boyton, R.J.; Altmann, D.M. 2002: Transgenic models of autoimmune disease. Clinical and Experimental Immunology 127(1): 4-11

Trojanowski, J.Q.; Lee, V.M. 1999: Transgenic models of tauopathies and synucleinopathies. Brain Pathology 9(4): 733-739

Kumar, T.R.; Palapattu, G.; Wang, P.; Woodruff, T.K.; Boime, I.; Byrne, M.C.; Matzuk, M.M. 1999: Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis. Molecular Endocrinology 13(6): 851-865

Solomon, A.; Weiss, D.T.; Schell, M.; Hrncic, R.; Murphy, C.L.; Wall, J.; McGavin, M.D.; Pan, H.J.; Kabalka, G.W.; Paulus, M.J. 1999: Transgenic mouse model of AA amyloidosis. American Journal of Pathology 154(4): 1267-1272

Higuchi, M.; Ishihara, T.; Zhang, B.; Hong, M.; Andreadis, A.; Trojanowski, J.; Lee, V.M-Y. 2002: Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Neuron 35(3): 433-446

Wistuba, J.; Schlatt, S. 2002: Transgenic mouse models and germ cell transplantation: two excellent tools for the analysis of genes regulating male fertility. Molecular Genetics and Metabolism 77(1-2): 61-67

Deng, H.X.; Siddique, T. 2000: Transgenic mouse models and human neurodegenerative disorders. Archives of Neurology 57(12): 1695-1702

Rahman, N.A.; Rilianawati, K.K.; Paukku, T.; Mikola, M.; Markkula, M.; Hamalainen, T.; Huhtaniemi, I.T. 1998: Transgenic mouse models for gonadal tumorigenesis. Molecular and Cellular Endocrinology 145(1-2): 167-174

Pegg, A.E.; Feith, D.J.; Fong, L.Y.Y.; Coleman, C.S.; O'Brien, T.G.; Shantz, L.M. 2003: Transgenic mouse models for studies of the role of polyamines in normal, hypertrophic and neoplastic growth. Biochemical Society Transactions 31(2): 356-360

Helminen, H.J.; Säämänen, A-M.; Salminen, H.; Hyttinen, M.M. 2002: Transgenic mouse models for studying the role of cartilage macromolecules in osteoarthritis. Rheumatology 41(8): 848-856

Beermann, F.; Hunziker, A.; Foletti, A. 1999: Transgenic mouse models for tumors of melanocytes and retinal pigment epithelium. Pigment Cell Research 12(2): 71-80

Carmeliet, P.; Collen, D. 2000: Transgenic mouse models in angiogenesis and cardiovascular disease. Journal of Pathology 190(3): 387-405

Thorgeirsson, S.S.; Factor, V.M.; Snyderwine, E.G. 2000: Transgenic mouse models in carcinogenesis research and testing. Toxicology Letters 112-113: 553-555

Higgins, G.A.; Jacobsen, H. 2003: Transgenic mouse models of Alzheimer's disease: phenotype and application. Behavioural Pharmacology 14(5-6): 419-438

Brede, M.; Hein, L. 2001: Transgenic mouse models of angiotensin receptor subtype function in the cardiovascular system. Regulatory Peptides 96(3): 125-132, 12 January

Chen, L.; Zhuang, X. 2003: Transgenic mouse models of dopamine deficiency. Annals of Neurology 54(Suppl 6): S91-102

Robertson, G.R.; Field, J.; Goodwin, B.; Bierach, S.; Tran, M.; Lehnert, A.; Liddle, C. 2003: Transgenic mouse models of human CYP3A4 gene regulation. Molecular Pharmacology 64(1): 42-50

Musarò, A.; Rosenthal, N. 1999: Transgenic mouse models of muscle aging. Experimental Gerontology 34(2): 147-156

Lee, V.M.; Trojanowski, J.Q. 2001: Transgenic mouse models of tauopathies: prospects for animal models of Pick's disease. Neurology 56(11 Suppl 4): S26-S30

Le Menuet, D.; Zennaro, M.C.; Viengchareun, S.; Lombès, M. 2000: Transgenic mouse models to study human mineralocorticoid receptor function in vivo. Kidney International 57(4): 1299-1306

De Winther, M.P.; Gijbels, M.J.; Van Dijk, K.W.; Havekes, L.M.; Hofker, M.H. 2000: Transgenic mouse models to study the role of the macrophage scavenger receptor class A in atherosclerosis. International Journal of Tissue Reactions 22(2-3): 85-91

Dean, S.W.; Brooks, T.M.; Burlinson, B.; Mirsalis, J.; Myhr, B.; Recio, L.; Thybaud, V. 1999: Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens. Mutagenesis 14(1): 141-151

Jin, C.; McKeehan, K.; Wang, F. 2003: Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens. Prostate 57(2): 160-164

Saillé, C.; Marin, P.; Martinou, J.C.; Nicole, A.; London, J.; Ceballos-Picot, I. 1999: Transgenic murine cortical neurons expressing human Bcl-2 exhibit increased resistance to amyloid beta-peptide neurotoxicity. Neuroscience 92(4): 1455-1463

Fernandez, B.; Buehler, A.; Wolfram, S.; Kostin, S.; Espanion, G.; Franz, W.M.; Niemann, H.; Doevendans, P.A.; Schaper, W.; Zimmermann, R. 2000: Transgenic myocardial overexpression of fibroblast growth factor-1 increases coronary artery density and branching. Circulation Research 87(3): 207-213

Yoh, K.; Sugawara, T.; Motohashi, H.; Takahama, Y.; Koyama, A.; Yamamoto, M.; Takahashi, S. 2001: Transgenic over-expression of MafK suppresses T cell proliferation and function in vivo. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 6(12): 1055-1066

Bacon, A.; Holmes, F.E.; Small, C.J.; Ghatei, M.; Mahoney, S.; Bloom, S.; Wynick, D. 2002: Transgenic over-expression of galanin in injured primary sensory neurons. Neuroreport 13(16): 2129-2132

Yoh, K.; Shibuya, K.; Morito, N.; Nakano, T.; Ishizaki, K.; Shimohata, H.; Nose, M.; Izui, S.; Shibuya, A.; Koyama, A.; Engel, J.D.; Yamamoto, M.; Takahashi, S. 2003: Transgenic overexpression of GATA-3 in T lymphocytes improves autoimmune glomerulonephritis in mice with a BXSB/MpJ-Yaa genetic background. Journal of the American Society of Nephrology: Jasn 14(10): 2494-2502

Wagner, M.; Weber, C.K.; Bressau, F.; Greten, F.R.; Stagge, V.; Ebert, M.; Leach, S.D.; Adler, G.; Schmid, R.M. 2002: Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells. Gastroenterology 122(7): 1898-1912

McGraw, D.W.; Forbes, S.L.; Mak, J.C.; Witte, D.P.; Carrigan, P.E.; Leikauf, G.D.; Liggett, S.B. 2000: Transgenic overexpression of beta(2)-adrenergic receptors in airway epithelial cells decreases bronchoconstriction. American Journal of Physiology. Lung Cellular and Molecular Physiology 279(2): L379-L389

McGraw, D.W.; Forbes, S.L.; Kramer, L.A.; Witte, D.P.; Fortner, C.N.; Paul, R.J.; Liggett, S.B. 1999: Transgenic overexpression of beta(2)-adrenergic receptors in airway smooth muscle alters myocyte function and ablates bronchial hyperreactivity. Journal of Biological Chemistry 274(45): 32241-32247

Aravamudan, B.; Volonte, D.; Ramani, R.; Gursoy, E.; Lisanti, M.P.; London, B.; Galbiati, F. 2003: Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype. Human Molecular Genetics 12(21): 2777-2788

Takeishi, Y.; Ping, P.; Bolli, R.; Kirkpatrick, D.L.; Hoit, B.D.; Walsh, R.A. 2000: Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy. Circulation Research 86(12): 1218-1223

García-Ocaña, A.; Vasavada, R.C.; Cebrian, A.; Reddy, V.; Takane, K.K.; López-Talavera, J.C.; Stewart, A.F. 2001: Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice. Diabetes 50(12): 2752-2762

Hansen, P.A.; Marshall, B.A.; Chen, M.; Holloszy, J.O.; Mueckler, M. 2000: Transgenic overexpression of hexokinase Ii in skeletal muscle does not increase glucose disposal in wild-type or Glut1-overexpressing mice. Journal of Biological Chemistry 275(29): 22381-22386

Kim, M.R.; Manoukian, R.; Yeh, R.; Silbiger, S.M.; Danilenko, D.M.; Scully, S.; Sun, J.; DeRose, M.L.; Stolina, M.; Chang, D.; Van, G.Y.; Clarkin, K.; Nguyen, H.Q.; Yu, Y.B.; Jing, S.; Senaldi, G.; Elliott, G.; Medlock, E.S. 2002: Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production. Blood 100(7): 2330-2340

Ahrén, B.; Oosterwijk, C.; Lips, C.J.; Höppener, J.W. 1998: Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice. Diabetologia 41(11): 1374-1380

Furbee, J.W.; Parks, J.S. 2002: Transgenic overexpression of human lecithin: Cholesterol acyltransferase (LCAT) in mice does not increase aortic cholesterol deposition. Atherosclerosis 165(1): 89-100

Lee, C.Geun.; Homer, R.J.; Cohn, L.; Link, H.; Jung, S.; Craft, J.E.; Graham, B.S.; Johnson, T.R.; Elias, J.A. 2002: Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. Journal of Biological Chemistry 277(38): 35466-35474

Ebihara, K.; Ogawa, Y.; Masuzaki, H.; Shintani, M.; Miyanaga, F.; Aizawa-Abe, M.; Hayashi, T.; Hosoda, K.; Inoue, G.; Yoshimasa, Y.; Gavrilova, O.; Reitman, M.L.; Nakao, K. 2001: Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes 50(6): 1440-1448

Pontén, A.; Li, X.; Thorén, P.; Aase, K.; Sjöblom, T.; Ostman, A.; Eriksson, U. 2003: Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. American Journal of Pathology 163(2): 673-682

Christopherson, K.W.; Campbell, J.J.; Hromas, R.A. 2001: Transgenic overexpression of the CC chemokine CCL21 disrupts T-cell migration. Blood 98(13): 3562-3568

Most, P.; Remppis, A.; Pleger, S.T.; Löffler, E.; Ehlermann, P.; Bernotat, J.; Kleuss, C.; Heierhorst, J.ör.; Ruiz, P.; Witt, H.; Karczewski, P.; Mao, L.; Rockman, H.A.; Duncan, S.J.; Katus, H.A.; Koch, W.J. 2003: Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance. Journal of Biological Chemistry 278(36): 33809-33817

Wagner, M.; Kunsch, S.; Duerschmied, D.; Beil, M.; Adler, G.; Mueller, F.; Gress, T.M. 2003: Transgenic overexpression of the oncofetal RNA binding protein KOC leads to remodeling of the exocrine pancreas. Gastroenterology 124(7): 1901-1914

Donzella, G.; Spena, A.; Rotino, G.L. 2000: Transgenic parthenocarpic eggplants: Superior germplasm for increased winter production. Molecular Breeding 6(1): 79-86

Van Cott, K.E.; Butler, S.P.; Russell, C.G.; Subramanian, A.; Lubon, H.; Gwazdauskas, F.C.; Knight, J.; Drohan, W.N.; Velander, W.H. 1999: Transgenic pigs as bioreactors: a comparison of gamma-carboxylation of glutamic acid in recombinant human protein C and factor IX by the mammary gland. Genetic Analysis: Biomolecular Engineering 15(3-5): 155-160

Stewart, C.N.; Richards, H.A.; Halfhill, M.D. 2000: Transgenic plants and biosafety: science, misconceptions and public perceptions. Biotechniques 29(4): 832

Domansky, N.N. 1999: Transgenic plants as edible vaccines - reality and future prospects. Biopolimery i Kletka 15(1): 5-9

Drake, P.M.W.; Chargelegue, D.; Vine, N.D.; Van Dolleweerd, C.J.; Obregon, P.; Ma, J.K-C. 2002: Transgenic plants expressing antibodies: a model for phytoremediation. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 16(14): 1855-1860

Hou, Y.M.; Sanders, R.; Ursin, V.M.; Gilbertson, R.L. 2000: Transgenic plants expressing geminivirus movement proteins: abnormal phenotypes and delayed infection by Tomato mottle virus in transgenic tomatoes expressing the Bean dwarf mosaic virus BV1 or BC1 proteins. Molecular plant-microbe interactions: MPMI 13(3): 297-308

Porceddu, A.; Falorni, A.; Ferradini, N.; Cosentino, A.; Calcinaro, F.; Faleri, C.; Cresti, M.; Lorenzetti, F.; Brunetti, P.; Pezzotti, M. 1999: Transgenic plants expressing human glutamic acid decarboxylase (GAD65), a major autoantigen in insulin-dependent diabetes mellitus. Molecular Breeding 5(6): 553-560

Chargelegue, D.; Obregon, P.; Drake, P.M. 2001: Transgenic plants for vaccine production: expectations and limitations. Trends in Plant Science 6(11): 495-496

Kuzniak, E. 2002: Transgenic plants: An insight into oxidative stress tolerance mechanisms. Acta Physiologiae Plantarum 24(1): 97-113

Kumar Singh, B.; Sharma, D.; Kumar Singh, A.; Tripathi, K.K. 1999: Transgenic plants: Tool for integrated pest management. International Journal of Tropical Agriculture 17(1-4): 263-277

Maimann, S.; Wagner, C.; Kreft, O.; Zeh, M.; Willmitzer, L.; Höfgen, R.; Hesse, H. 2000: Transgenic potato plants reveal the indispensable role of cystathionine beta-lyase in plant growth and development. Plant Journal: for Cell and Molecular Biology 23(6): 747-758

Backhausen, J.E.; Emmerlich, A.; Holtgrefe, S.; Horton, P.; Nast, G.; Rogers, J.J.M.; Mueller Roeber, B.; Scheibe, R. 1998: Transgenic potato plants with altered levels of chloroplast NADP-malate dehydrogenase: Interactions between photosynthetic electron transport and malate metabolism in leaves and in isolated intact chloroplasts. Planta (Berlin) 207(1): 105-114

Behboodi, E.; Groen, W.; Destrempes, M.M.; Williams, J.L.; Ohlrichs, C.; Gavin, W.G.; Broek, D.M.; Ziomek, C.A.; Faber, D.C.; Meade, H.M.; Echelard, Y. 2001: Transgenic production from in vivo-derived embryos: effect on calf birth weight and sex ratio. Molecular Reproduction and Development 60(1): 27-37

Fan, J.; Challah, M.; Watanabe, T. 1999: Transgenic rabbit models for biomedical research: Current status, basic methods and future perspectives. Pathology International 49(7): 583-594

Brousseau, M.E.; Hoeg, J.M. 1999: Transgenic rabbits as models for atherosclerosis research. Journal of Lipid Research 40(3): 365-375

Zinov'eva, N.A.; Bezenfelder, U.; Muller, M.; Ernst, L.K.; Brem, G. 1998: Transgenic rabbits as producers of cattle chymosin with milk. Biotekhnologiya 1998(4): 17-31

Fan, J.; Shimoyamada, H.; Sun, H.; Marcovina, S.; Honda, K.; Watanabe, T. 2001: Transgenic rabbits expressing human apolipoprotein(a) develop more extensive atherosclerotic lesions in response to a cholesterol-rich diet. Arteriosclerosis Thrombosis and Vascular Biology 21(1): 88-94

James, J.; Zhang, Y.; Wright, K.; Witt, S.; Glascock, E.; Osinska, H.; Klevitsky, R.; Martin, L.; Yager, K.; Sanbe, A.; Robbins, J. 2002: Transgenic rabbits expressing mutant essential light chain do not develop hypertrophic cardiomyopathy. Journal of Molecular and Cellular Cardiology 34(7): 873-882

Frey, N.; Franz, W.M.; Gloeckner, K.; Degenhardt, M.; Müller, M.; Müller, O.; Merz, H.; Katus, H.A. 2000: Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias. Cardiovascular Research 47(2): 254-264

Müller, O.J.; Lange, M.; Rattunde, H.; Lorenzen, H-Peter.; Müller, M.; Frey, N.; Bittner, C.; Simonides, W.; Katus, H.A.; Franz, W.M. 2003: Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload. Cardiovascular Research 59(2): 380-389

Ota, T.; Asamoto, M.; Toriyama-Baba, H.; Yamamoto, F.; Matsuoka, Y.; Ochiya, T.; Sekiya, T.; Terada, M.; Akaza, H.; Tsuda, H. 2000: Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis. Carcinogenesis 21(7): 1391-1396

Asamoto, M.; Toriyama-Baba, H.; Ohnishi, T.; Naito, A.; Ota, T.; Ando, A.; Ochiya, T.; Tsuda, H. 2002: Transgenic rats carrying human c-Ha-ras proto-oncogene are highly susceptible to N-nitrosomethylbenzylamine induction of esophageal tumorigenesis. Japanese Journal of Cancer Research: Gann 93(7): 744-751

Asamoto, M.; Ochiya, T.; Toriyama-Baba, H.; Ota, T.; Sekiya, T.; Terada, M.; Tsuda, H. 2000: Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis. Carcinogenesis 21(2): 243-249

Liefeldt, L.; Schönfelder, G.; Böcker, W.; Hocher, B.; Talsness, C.E.; Rettig, R.; Paul, M. 1999: Transgenic rats expressing the human ET-2 gene: A model for the study of endothelin actions in vivo. Journal of Molecular Medicine 77(7): 565-574

Thorens, B.; Guillam, M.T.; Beermann, F.; Burcelin, R.; Jaquet, M. 2000: Transgenic reexpression of GLUT1 or GLUT2 in pancreatic beta cells rescues GLUT2-null mice from early death and restores normal glucose-stimulated insulin secretion. Journal of Biological Chemistry 275(31): 23751-23758

Hamilton-Williams, E.E.; Serreze, D.V.; Charlton, B.; Johnson, E.A.; Marron, M.P.; Mullbacher, A.; Slattery, R.M. 2001: Transgenic rescue implicates beta2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice. Proceedings of the National Academy of Sciences of the United States of America 98(20): 11533-11538

Rice, J.; Doggett, B.; Sweetser, D.A.; Yanagisawa, H.; Yanagisawa, M.; Kapur, R.P. 2000: Transgenic rescue of aganglionosis and piebaldism in lethal spotted mice. Developmental Dynamics: An Official Publication of the American Association of Anatomists 217(1): 120-132

Li, J.; Liu, K.C.; Jin, F.; Lu, M.M.; Epstein, J.A. 1999: Transgenic rescue of congenital heart disease and spina bifida in Splotch mice. Development 126(11): 2495-2503

Martelli, G.P. 2001: Transgenic resistance to plant pathogens: Benefits and risks. Journal of Plant Pathology 83(2 Special Issue): 37-46

Acciarri, N.V.telli, G.A.paia, S.M.nnella, G.S.nseri, F.R.tino, G. 2000: Transgenic resistance to the Colorado potato beetle in Bt-expressing eggplant fields. HortScience 35(4): 722-725

Gahakwa, D.; Maqbool, S.B.; Fu, X.; Sudhakar, D.; Christou, P.; Kohli, A. 2000: Transgenic rice as a system to study the stability of transgene expression: Multiple heterologous transgenes show similar behaviour in diverse genetic backgrounds. Theoretical and Applied Genetics 101(3): 388-399

Maruta, Y.U.ki, J.S.ito, H.N.tta, N.I.aseki, H. 2001: Transgenic rice with reduced glutelin content by transformation with glutelin A antisense gene. Molecular breeding: new strategies in plant improvement(4): 273-284

Floryanowicz-Czekalska, K.; Wysokinska, H. 2000: Transgenic shoots and plants as a source of natural phytochemical products. Acta Societatis Botanicorum Poloniae 69(2): 131-136

Belcher, J.D.; Bryant, C.J.; Nguyen, J.; Bowlin, P.R.; Kielbik, M.C.; Bischof, J.C.; Hebbel, R.P.; Vercellotti, G.M. 2003: Transgenic sickle mice have vascular inflammation. Blood 101(10): 3953-3959

Munsie, M.; O'brien, C.; Mountford, P. 2002: Transgenic strategy for demonstrating nuclear reprogramming in the mouse. Cloning and Stem Cells 4(2): 121-130

Murphy, D.; Xu, J.; Waller, S. 2000: Transgenic studies in rats and mice on the osmotic regulation of vasopressin gene expression. Experimental Physiology 85 Spec No: 211s-222s

Tanoue, A.; Koshimizu, T.-a.; Tsujimoto, G. 2002: Transgenic studies of alpha(1)-adrenergic receptor subtype function. Life Sciences 71(19): 2207-2215

Eckhart, A.D.; Koch, W.J. 2001: Transgenic studies of cardiac adrenergic receptor regulation. Journal of Pharmacology and Experimental Therapeutics 299(1): 1-5

Kurtz, D.M.; Tian, L.; Gower, B.A.; Nagy, T.R.; Pinkert, C.A.; Wood, P.A. 2000: Transgenic studies of fatty acid oxidation gene expression in nonobese diabetic mice. Journal of Lipid Research 41(12): 2063-2070

Lariviere, W.R.; Chesler, E.J.; Mogil, J.S. 2001: Transgenic studies of pain and analgesia: mutation or background genotype?. Journal of Pharmacology and Experimental Therapeutics 297(2): 467-473

Messing, A. 1998: Transgenic studies of peripheral and central glia. International Journal of Developmental Biology 42(7): 1019-1024

Inui, A. 2000: Transgenic study of energy homeostasis equation: implications and confounding influences. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 14(14): 2158-2170

Chen, L-Ying.; Li, P.; He, Q.; Jiang, L-Qun.; Cui, C-Jue.; Xu, L.; Liu, L-Sheng. 2002: Transgenic study of the function of chymase in heart remodeling. Journal of Hypertension 20(10): 2047-2055

Moran, R.; Garcia, R.; Lopez, A.; Zaldua, Z.; Mena, J.; Garcia, M.; Armas, R.; Somonte, D.; Rodriguez, J.; Gomez, M.; Pimentel, E. 1998: Transgenic sweet potato plants carrying the delta-endotoxin gene from Bacillus thuringiensis var. tenebrionis. Plant Science (Shannon) 139(2): 175-184

Kulick, D.M.; Salerno, C.T.; Dalmasso, A.P.; Park, S.J.; Paz, M.G.; Fodor, W.L.; Bolman, R.M. 2000: Transgenic swine lungs expressing human CD59 are protected from injury in a pig-to-human model of xenotransplantation. Journal of Thoracic and Cardiovascular Surgery 119(4 Pt 1): 690-699

Törnell, J.; Snaith, M. 2002: Transgenic systems in drug discovery: From target identification to humanized mice. Drug Discovery Today 7(8): 461-470

Feng, X.; Jiang, Y.; Meltzer, P.; Yen, P.M. 2001: Transgenic targeting of a dominant negative corepressor to liver blocks basal repression by thyroid hormone receptor and increases cell proliferation. Journal of Biological Chemistry 276(18): 15066-15072

Radomska, H.S.; Gonzalez, D.A.; Okuno, Y.; Iwasaki, H.; Nagy, A.; Akashi, K.; Tenen, D.G.; Huettner, C.S. 2002: Transgenic targeting with regulatory elements of the human CD34 gene. Blood 100(13): 4410-4419

McGraw, D.W. 2002: Transgenic techniques to delineate cell-specific effects of beta2-adrenergic receptors in the lung. Journal of Allergy and Clinical Immunology 110(6 Suppl): S236-S241

Bak, S.; Olsen, C.E.; Halkier, B.A.; Møller, B.L. 2000: Transgenic tobacco and Arabidopsis plants expressing the two multifunctional sorghum cytochrome P450 enzymes, CYP79A1 and CYP71E1, are cyanogenic and accumulate metabolites derived from intermediates in Dhurrin biosynthesis. Plant Physiology 123(4): 1437-1448

Libantova, J.; Bauer, M.; Mlynarova, L'udmila; Moravcikova, J.; Bekesiova, I. 1998: Transgenic tobacco and potato plants expressing basic vacuolar beta-1,3-glucanase from Nicotiana plumbaginifolia. Biologia (Bratislava) 53(6): 739-748

Oh, S.H.; Park, Y.S.; Yang, M.S. 1999: Transgenic tobacco plants expressing a mutant VU-4 calmodulin have altered nicotinamide co-enzyme levels and hydrogen peroxide levels. Journal of Biochemistry and Molecular Biology 32(1): 1-5

Park, J.M.; Kwon, S.Y.; Song, K.B.; Kwak, J.W.; Lee, S.B.; Nam, Y.W.; Shin, J.S.; Park, Y.I.; Rhee, S.K.; Paek, K.H. 1999: Transgenic tobacco plants expressing the bacterial levansucrase gene show enhanced tolerance to osmotic stress. Journal of Microbiology and Biotechnology 9(2): 213-218

Ryu, K.H.; Lee, G.P.; Park, K.W.; Lee, S.Y.; Park, W.M. 1998: Transgenic tobacco plants expressing the coat protein of cucumber mosaic virus show different virus resistance. Journal of Plant Biology 41(4): 255-261

Zhang-Xiao-Yu; Zhou-Wei; Ru-Bing-Gen 2000: Transgenic tobacco with alphaalpha mutant gene has higher tolerance to heavy metals. Acta Botanica Sinica 42(4): 416-420

Monti, M.M.; Valanzuolo, S.; Cassani, G.; Colombo, M. 1999: Transgenic tomatoes expressing a Cucumber Mosaic Virus satellite RNA: Field testing and analysis of satellite RNA spread. Journal of Plant Pathology 81(2): 113-122

Storer, R.D.; French, J.E.; Donehower, L.A.; Gulezian, D.; Mitsumori, K.; Recio, L.; Schiestl, R.H.; Sistare, F.D.; Tamaoki, N.; Usui, T.; Van Steeg, H. 2003: Transgenic tumor models for carcinogen identification: The heterozygous Trp53-deficient and RasH2 mouse lines. Mutation Research 540(2): 165-176

Gou, K.M.; An, X.R.; Guan, H.; Yang, X.Y.; Hou, J.; Zhu, S.E.; Zeng, S.M.; Tian, J.H.; Chen, Y.F. 2003: Transgenic twin lambs cloned by granulosa cells. Cloning and Stem Cells 5(1): 71-78

Desplanque, B.; Hautekeete, N.; Van Dijk, H. 2002: Transgenic weed beets: Possible, probable, avoidable?. Journal of Applied Ecology 39(4): 561-571

Pellegrineschi, A.; Mclean, S.; Salgado, M.; Velazquez, L.; Hernandez, R.; Brito, R.M.; Noguera, M.; Medhurst, A.; Hoisington, D. 2001: Transgenic wheat plants: A powerful breeding source. Euphytica 119(1-2): 133-136

Tomasiewicz, H.G.; Flaherty, D.B.; Soria, J.P.; Wood, J.G. 2002: Transgenic zebrafish model of neurodegeneration. Journal of Neuroscience Research 70(6): 734-745

Zhao, X.; Zhang, Z.; Song, Y.; Zhang, X.; Zhang, Y.; Hu, Y.; Fromm, S.H.; Chen, Y. 2000: Transgenically ectopic expression of Bmp4 to the Msx1 mutant dental mesenchyme restores downstream gene expression but represses Shh and Bmp2 in the enamel knot of wild type tooth germ. Mechanisms of Development 99(1-2): 29-38

Marek, K.W.; Davis, G.W. 2002: Transgenically encoded protein photoinactivation (FlAsH-FALI): Acute inactivation of synaptotagmin I. Neuron 36(5): 805-813

Brunetti, A.; Tavazza, R.; Noris, E.; Lucioli, A.; Accotto, G.P.; Tavazza, M. 2001: Transgenically expressed T-Rep of tomato yellow leaf curl Sardinia virus acts as a trans-dominant-negative mutant, inhibiting viral transcription and replication. Journal of Virology 75(22): 10573-10581

Mohanty, A.; Kathuria, H.; Ferjani, A.; Sakamoto, A.; Mohanty, P.; Murata, N.; Tyagi, A.K. 2002: Transgenics of an elite indica rice variety Pusa Basmati 1 harbouring the codA gene are highly tolerant to salt stress. Tag. Theoretical and Applied Genetics. Theoretische und Angewandte Genetik 106(1): 51-57